0000866439 2025-01-01 2025-12-31 0000866439 2025-12-31 0000866439 2024-12-31 0000866439 us-gaap:SeriesAPreferredStockMember 2025-12-31 0000866439 us-gaap:SeriesAPreferredStockMember 2024-12-31 0000866439 DPLS:SeriesDConvertiblePreferredStockMember 2025-12-31 0000866439 DPLS:SeriesDConvertiblePreferredStockMember 2024-12-31 0000866439 2024-01-01 2024-12-31 0000866439 DPLS:PreferredStockSeriesAMember 2023-12-31 0000866439 DPLS:PreferredStockSeriesDMember 2023-12-31 0000866439 us-gaap:CommonStockMember 2023-12-31 0000866439 DPLS:CommonStockToBeIssuedMember 2023-12-31 0000866439 DPLS:PreferredStockSeriesAMember 2024-12-31 0000866439 DPLS:PreferredStockSeriesDMember 2024-12-31 0000866439 us-gaap:CommonStockMember 2024-12-31 0000866439 DPLS:CommonStockToBeIssuedMember 2024-12-31 0000866439 us-gaap:TreasuryStockCommonMember 2023-12-31 0000866439 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000866439 us-gaap:NoncontrollingInterestMember 2023-12-31 0000866439 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000866439 us-gaap:RetainedEarningsMember 2023-12-31 0000866439 2023-12-31 0000866439 us-gaap:TreasuryStockCommonMember 2024-12-31 0000866439 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000866439 us-gaap:NoncontrollingInterestMember 2024-12-31 0000866439 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000866439 us-gaap:RetainedEarningsMember 2024-12-31 0000866439 DPLS:PreferredStockSeriesAMember 2024-01-01 2024-12-31 0000866439 DPLS:PreferredStockSeriesDMember 2024-01-01 2024-12-31 0000866439 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000866439 DPLS:CommonStockToBeIssuedMember 2024-01-01 2024-12-31 0000866439 DPLS:PreferredStockSeriesAMember 2025-01-01 2025-12-31 0000866439 DPLS:PreferredStockSeriesDMember 2025-01-01 2025-12-31 0000866439 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0000866439 DPLS:CommonStockToBeIssuedMember 2025-01-01 2025-12-31 0000866439 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0000866439 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000866439 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-12-31 0000866439 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0000866439 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000866439 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-12-31 0000866439 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-12-31 0000866439 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-12-31 0000866439 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-12-31 0000866439 us-gaap:RetainedEarningsMember 2025-01-01 2025-12-31 0000866439 DPLS:PreferredStockSeriesAMember 2025-12-31 0000866439 DPLS:PreferredStockSeriesDMember 2025-12-31 0000866439 us-gaap:CommonStockMember 2025-12-31 0000866439 DPLS:CommonStockToBeIssuedMember 2025-12-31 0000866439 us-gaap:TreasuryStockCommonMember 2025-12-31 0000866439 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000866439 us-gaap:NoncontrollingInterestMember 2025-12-31 0000866439 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0000866439 us-gaap:RetainedEarningsMember 2025-12-31 0000866439 DPLS:CarebournMember 2025-01-01 2025-12-31 0000866439 DPLS:OtherAccountsMember 2025-01-01 2025-12-31 0000866439 currency:GBP 2025-12-31 0000866439 currency:CAD 2025-12-31 0000866439 currency:AED 2025-12-31 0000866439 currency:INR 2025-12-31 0000866439 currency:TRY 2025-12-31 0000866439 currency:GBP 2024-12-31 0000866439 currency:CAD 2024-12-31 0000866439 currency:INR 2024-12-31 0000866439 currency:TRY 2024-12-31 0000866439 DPLS:JointVentureTransactionMember 2025-12-31 0000866439 DPLS:JointVentureTransactionMember 2025-01-01 2025-12-31 0000866439 DPLS:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0000866439 us-gaap:FurnitureAndFixturesMember 2025-12-31 0000866439 srt:MinimumMember us-gaap:PropertyPlantAndEquipmentMember 2025-12-31 0000866439 srt:MaximumMember us-gaap:PropertyPlantAndEquipmentMember 2025-12-31 0000866439 us-gaap:LeaseholdImprovementsMember 2025-12-31 0000866439 DPLS:MotorVehiclesMember 2025-12-31 0000866439 DPLS:ConvertibleNotesMember 2025-01-01 2025-12-31 0000866439 DPLS:ConvertibleNotesMember 2024-01-01 2024-12-31 0000866439 us-gaap:SeriesDPreferredStockMember 2025-01-01 2025-12-31 0000866439 us-gaap:SeriesDPreferredStockMember 2024-01-01 2024-12-31 0000866439 DPLS:OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember 2024-09-10 2024-09-11 0000866439 DPLS:OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember DPLS:AmountsRecognizedAsOfAcquisitionDateMember 2024-09-11 0000866439 DPLS:OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember DPLS:MeasurementPeriodAdjustmentsMember 2024-09-11 0000866439 DPLS:OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember 2024-09-11 0000866439 us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-12-31 0000866439 us-gaap:TransferredAtPointInTimeMember 2024-01-01 2024-12-31 0000866439 us-gaap:TransferredOverTimeMember 2025-01-01 2025-12-31 0000866439 us-gaap:TransferredOverTimeMember 2024-01-01 2024-12-31 0000866439 us-gaap:ProductMember 2025-01-01 2025-12-31 0000866439 us-gaap:ProductMember 2024-01-01 2024-12-31 0000866439 us-gaap:ServiceMember 2025-01-01 2025-12-31 0000866439 us-gaap:ServiceMember 2024-01-01 2024-12-31 0000866439 srt:NorthAmericaMember 2025-01-01 2025-12-31 0000866439 srt:NorthAmericaMember 2024-01-01 2024-12-31 0000866439 country:GB 2024-01-01 2024-12-31 0000866439 DPLS:RestOfWorldMember 2025-01-01 2025-12-31 0000866439 DPLS:RestOfWorldMember 2024-01-01 2024-12-31 0000866439 us-gaap:PropertyPlantAndEquipmentMember 2025-12-31 0000866439 us-gaap:PropertyPlantAndEquipmentMember 2024-12-31 0000866439 us-gaap:LeaseholdImprovementsMember 2024-12-31 0000866439 us-gaap:TechnologyBasedIntangibleAssetsMember 2025-01-01 2025-12-31 0000866439 us-gaap:TechnologyBasedIntangibleAssetsMember 2024-01-01 2024-12-31 0000866439 DPLS:DPTIPatentsMember 2025-12-31 0000866439 DPLS:DPTIPatentsMember 2024-12-31 0000866439 DPLS:DPTIMember 2025-12-31 0000866439 DPLS:NeuralSignalsIncMember 2022-09-09 0000866439 2023-01-01 2023-12-31 0000866439 2022-01-01 2022-12-31 0000866439 DPLS:Sept2025NotePayableMember 2025-09-05 0000866439 DPLS:Nov2025NotePayableMember 2025-09-05 0000866439 DPLS:Nov2025NotePayableMember 2025-11-24 0000866439 DPLS:Dec2025NotePayableMember 2025-09-05 0000866439 DPLS:Dec2025NotePayableMember 2025-12-03 0000866439 DPLS:RILineOfCreditMember 2025-12-31 0000866439 DPLS:RILineOfCreditMember 2024-12-31 0000866439 DPLS:RIShortTermLoansMember 2025-12-31 0000866439 DPLS:RIShortTermLoansMember 2024-12-31 0000866439 DPLS:WSLineOfCreditMember 2025-12-31 0000866439 DPLS:WSLineOfCreditMember 2024-12-31 0000866439 DPLS:WSShortTermLoansMember 2025-12-31 0000866439 DPLS:WSShortTermLoansMember 2024-12-31 0000866439 DPLS:OptilanCommunicationSecurityLtdShortTermLoanMember 2025-12-31 0000866439 DPLS:OptilanCommunicationSecurityLtdShortTermLoanMember 2024-12-31 0000866439 DPLS:OptilianIndiaDirectorLoansMember 2025-12-31 0000866439 DPLS:OptilianIndiaDirectorLoansMember 2024-12-31 0000866439 DPLS:RISBAEIDLMember 2025-12-31 0000866439 DPLS:RISBAEIDLMember 2024-12-31 0000866439 DPLS:RILongTermLoansMember 2025-12-31 0000866439 DPLS:RILongTermLoansMember 2024-12-31 0000866439 DPLS:WSSBAEIDLMember 2025-12-31 0000866439 DPLS:WSSBAEIDLMember 2024-12-31 0000866439 DPLS:WSLongTermLoansMember 2025-12-31 0000866439 DPLS:WSLongTermLoansMember 2024-12-31 0000866439 us-gaap:PreferredStockMember 2025-12-31 0000866439 us-gaap:PreferredStockMember 2024-12-31 0000866439 us-gaap:CommonStockMember 2025-12-31 0000866439 us-gaap:CommonStockMember 2024-12-31 0000866439 DPLS:EquityFinancingAgreementMember 2024-11-05 2024-11-06 0000866439 DPLS:EquityFinancingAgreementMember 2023-01-10 2023-01-12 0000866439 DPLS:EquityFinancingAgreementMember 2023-01-12 0000866439 DPLS:EquityFinancingAgreementMember 2023-01-16 2023-01-17 0000866439 DPLS:EquityFinancingAgreementMember 2023-01-17 0000866439 DPLS:EquityFinancingAgreementMember 2023-01-23 2023-01-24 0000866439 DPLS:EquityFinancingAgreementMember 2023-01-24 0000866439 DPLS:EquityFinancingAgreementMember 2023-02-02 2023-02-03 0000866439 DPLS:EquityFinancingAgreementMember 2023-02-03 0000866439 DPLS:EquityFinancingAgreementMember 2023-02-16 2023-02-17 0000866439 DPLS:EquityFinancingAgreementMember 2023-02-17 0000866439 DPLS:EquityFinancingAgreementMember 2023-02-28 2023-03-01 0000866439 DPLS:EquityFinancingAgreementMember 2023-03-01 0000866439 DPLS:EquityFinancingAgreementMember 2023-03-15 2023-03-16 0000866439 DPLS:EquityFinancingAgreementMember 2023-03-16 0000866439 DPLS:EquityFinancingAgreementMember 2023-03-29 2023-03-30 0000866439 DPLS:EquityFinancingAgreementMember 2023-03-30 0000866439 DPLS:EquityFinancingAgreementMember 2023-04-10 2023-04-11 0000866439 DPLS:EquityFinancingAgreementMember 2023-04-11 0000866439 DPLS:EquityFinancingAgreementMember 2023-04-27 2023-04-28 0000866439 DPLS:EquityFinancingAgreementMember 2023-04-28 0000866439 DPLS:EquityFinancingAgreementMember 2023-06-25 2023-06-26 0000866439 DPLS:EquityFinancingAgreementMember 2023-06-26 0000866439 DPLS:EquityFinancingAgreementMember 2023-07-02 2023-07-03 0000866439 DPLS:EquityFinancingAgreementMember 2023-07-03 0000866439 DPLS:EquityFinancingAgreementMember 2023-07-09 2023-07-10 0000866439 DPLS:EquityFinancingAgreementMember 2023-07-10 0000866439 DPLS:EquityFinancingAgreementMember 2023-09-04 2023-09-05 0000866439 DPLS:EquityFinancingAgreementMember 2023-09-05 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-06 2023-11-07 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-07 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-05 2023-11-08 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-08 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-13 2023-11-14 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-14 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-21 2023-11-22 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-22 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-28 2023-11-29 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-29 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-27 2023-11-30 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-30 0000866439 DPLS:EquityFinancingAgreementMember 2023-11-28 2023-12-01 0000866439 DPLS:EquityFinancingAgreementMember 2023-12-01 0000866439 DPLS:EquityFinancingAgreementOneMember 2023-11-28 2023-12-01 0000866439 DPLS:EquityFinancingAgreementOneMember 2023-12-01 0000866439 DPLS:EquityFinancingAgreementMember 2023-12-10 2023-12-11 0000866439 DPLS:EquityFinancingAgreementMember 2023-12-11 0000866439 DPLS:EquityFinancingAgreementMember 2023-12-26 2023-12-27 0000866439 DPLS:EquityFinancingAgreementMember 2023-12-27 0000866439 DPLS:EquityFinancingAgreementMember 2024-01-07 2024-01-08 0000866439 DPLS:EquityFinancingAgreementMember 2024-01-08 0000866439 DPLS:EquityFinancingAgreementMember 2024-02-28 2024-02-29 0000866439 DPLS:EquityFinancingAgreementMember 2024-02-29 0000866439 DPLS:EquityFinancingAgreementMember 2024-08-18 2024-08-19 0000866439 DPLS:EquityFinancingAgreementMember 2024-08-19 0000866439 DPLS:EquityFinancingAgreementMember 2023-01-01 2024-12-31 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-05 2025-01-06 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-06 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-13 2025-01-14 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-14 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-23 2025-01-24 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-24 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-29 2025-01-30 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-30 0000866439 DPLS:EquityFinancingAgreementMember 2025-02-06 2025-02-07 0000866439 DPLS:EquityFinancingAgreementMember 2025-02-07 0000866439 DPLS:EquityFinancingAgreementMember 2025-02-17 2025-02-18 0000866439 DPLS:EquityFinancingAgreementMember 2025-02-18 0000866439 DPLS:EquityFinancingAgreementMember 2025-02-27 2025-02-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-02-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-03-09 2025-03-10 0000866439 DPLS:EquityFinancingAgreementMember 2025-03-10 0000866439 DPLS:EquityFinancingAgreementMember 2025-03-17 2025-03-18 0000866439 DPLS:EquityFinancingAgreementMember 2025-03-18 0000866439 DPLS:EquityFinancingAgreementMember 2025-03-27 2025-03-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-03-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-04-03 2025-04-04 0000866439 DPLS:EquityFinancingAgreementMember 2025-04-04 0000866439 DPLS:EquityFinancingAgreementMember 2025-04-13 2025-04-14 0000866439 DPLS:EquityFinancingAgreementMember 2025-04-14 0000866439 DPLS:EquityFinancingAgreementMember 2025-04-22 2025-04-23 0000866439 DPLS:EquityFinancingAgreementMember 2025-04-23 0000866439 DPLS:EquityFinancingAgreementMember 2025-04-30 2025-05-01 0000866439 DPLS:EquityFinancingAgreementMember 2025-05-01 0000866439 DPLS:EquityFinancingAgreementMember 2025-05-08 2025-05-09 0000866439 DPLS:EquityFinancingAgreementMember 2025-05-09 0000866439 DPLS:EquityFinancingAgreementMember 2025-05-20 2025-05-21 0000866439 DPLS:EquityFinancingAgreementMember 2025-05-21 0000866439 DPLS:EquityFinancingAgreementMember 2025-05-29 2025-05-30 0000866439 DPLS:EquityFinancingAgreementMember 2025-05-30 0000866439 DPLS:EquityFinancingAgreementMember 2025-06-09 2025-06-10 0000866439 DPLS:EquityFinancingAgreementMember 2025-06-10 0000866439 DPLS:EquityFinancingAgreementMember 2025-06-19 2025-06-20 0000866439 DPLS:EquityFinancingAgreementMember 2025-06-20 0000866439 DPLS:EquityFinancingAgreementMember 2025-07-01 2025-07-02 0000866439 DPLS:EquityFinancingAgreementMember 2025-07-02 0000866439 DPLS:EquityFinancingAgreementMember 2025-07-20 2025-07-21 0000866439 DPLS:EquityFinancingAgreementMember 2025-07-21 0000866439 DPLS:EquityFinancingAgreementMember 2025-08-21 2025-08-22 0000866439 DPLS:EquityFinancingAgreementMember 2025-08-22 0000866439 DPLS:EquityFinancingAgreementMember 2025-09-03 2025-09-04 0000866439 DPLS:EquityFinancingAgreementMember 2025-09-04 0000866439 DPLS:EquityFinancingAgreementMember 2025-09-11 2025-09-12 0000866439 DPLS:EquityFinancingAgreementMember 2025-09-12 0000866439 DPLS:EquityFinancingAgreementMember 2025-09-22 2025-09-23 0000866439 DPLS:EquityFinancingAgreementMember 2025-09-23 0000866439 DPLS:EquityFinancingAgreementMember 2025-09-29 2025-10-02 0000866439 DPLS:EquityFinancingAgreementMember 2025-10-02 0000866439 DPLS:EquityFinancingAgreementMember 2025-10-09 2025-10-10 0000866439 DPLS:EquityFinancingAgreementMember 2025-10-10 0000866439 DPLS:EquityFinancingAgreementMember 2025-10-27 2025-10-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-10-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-11-10 2025-11-11 0000866439 DPLS:EquityFinancingAgreementMember 2025-11-11 0000866439 DPLS:EquityFinancingAgreementMember 2025-11-27 2025-11-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-11-28 0000866439 DPLS:EquityFinancingAgreementMember 2025-12-08 2025-12-09 0000866439 DPLS:EquityFinancingAgreementMember 2025-12-09 0000866439 DPLS:EquityFinancingAgreementMember 2025-12-17 2025-12-18 0000866439 DPLS:EquityFinancingAgreementMember 2025-12-18 0000866439 DPLS:EquityFinancingAgreementMember 2025-01-01 2025-12-31 0000866439 DPLS:OptilanMember 2025-01-01 2025-12-31 0000866439 DPLS:OptilanMember 2024-01-01 2024-12-31 0000866439 DPLS:RemoteIntelligenceMember 2025-12-31 0000866439 DPLS:RemoteIntelligenceMember 2024-12-31 0000866439 DPLS:WildlifeSpecialistsMember 2025-12-31 0000866439 DPLS:WildlifeSpecialistsMember 2024-12-31 iso4217:USD shares iso4217:USD shares pure DPLS:Integer false 2025 Q1 0000866439 POS AM 1 1 DARKPULSE, INC. DE 87-0472109 2325 E Camelback Rd, Suite 400 Phoenix AZ 85016 (800) 436-1436 Non-accelerated Filer true false It is management’s practice to approve ordinary course annual equity grants during a scheduled meeting held each year. At this meeting, management will approve each named executive officer’s annual equity award, if any. At this time, we do not currently anticipate granting stock options to any of our named executive officers. We do <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90F_eecd--AwardTmgMnpiCnsdrdFlag_dbT_c20250101__20251231_zC8bHoT4rFi4">not</span> schedule our equity grants in anticipation of the release of material, non-public information, nor do we time the release of material nonpublic information based on equity grant dates. true 62786 86531 419212 915044 61946 102782 543944 1104357 546447 698982 0 449556 151607 202635 0 0 0 0 0 0 0 23965 125932 308804 0 0 823986 1683942 1367930 2788299 18643326 16863559 181000 114000 316099 -57235 359805 571530 365622 361747 273225 260550 0 80400 126063 70513 20265140 18265063 341532 781094 281416 291967 0 447009 622948 1520070 20888088 19785133 0.01 0.01 100 100 100 100 100 100 1 1 0.01 0.01 100000 100000 88235 88235 88235 88235 883 883 0.0001 0.0001 20000000000 20000000000 90904606 90904606 40500587 40500587 9090 5276 1000 1000 1000 1000 53898122 52213244 1950123 2464519 1248238 1207006 -2399122 -1627086 -74226493 -71259677 -19520158 -16996834 1367930 2788299 308492 126836 98901 2266 209591 124570 879720 471588 897919 824630 241700 516756 85198 128489 741380 59817 23965 0 222092 -0 2647790 2001280 -2438199 -1876710 135802 628104 11381 0 -407594 -60291 0 -1500000 181055 161045 -18772 12648 -110573 0 -1524 -2447 -481829 -2017149 5554 -0 -2925582 -3893859 41232 -10404 -2966814 -3883455 -0.04 -0.04 -0.00 -0.00 72028019 8213651977 -2925582 -3893859 -772036 -373729 -3697618 -4267588 100 1 88235 883 40500589 3992 0 205000 9619527 1103 277778 28 556339 56 972222 97 11527778 2446046 1111111 28 922222 -186555 100 1 88235 883 52759788 5276 12727778 2464519 26473083 3099 1058192 107 10002709 497 -10002709 -514286 1096350 111 -600000 -111 -485516 100 1 88235 883 90904606 9090 2125069 1950123 500 -1000 50527972 1217410 -1253356 -67376222 -16675319 1001852 1002983 109464 109520 307933 2754076 241145 54618 -373730 -373730 24878 24878 -10404 -3883455 -3893859 500 -1000 52213244 1207006 -1627086 -71259677 -16996834 1129321 1132420 42220 42327 513789 0 -0 -452 -772036 -772488 0 0 0 0 0 0 -41232 -2966814 -2925582 500 -1000 53898122 1248238 -2399122 -74226493 -19520158 -2925582 -3893859 85198 128489 181055 161045 407594 60291 -0 -1500000 741380 59817 -18772 -0 0 47129 -110573 -0 -11381 -0 23965 0 222092 -0 145548 46096 -123708 173724 1949843 1361330 -527409 -170251 13233 -226432 -449556 -0 0 0 -66483 -1514351 -0 33162 -0 29817 -0 30000 0 -92979 1174296 3946075 160000 0 -387555 -1866432 946741 2079643 880258 472314 -904003 -397695 86531 11912 62786 86531 30782 18971 0 0 42328 109521 221567 0 <p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zEJM6dsv77k9" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>NOTE 1 – <span id="xdx_824_zogYFbXa4kH6">BASIS OF FINANCIAL STATEMENT PRESENTATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b><i>Organization and Description of Business</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">DarkPulse, Inc. (“DPI” or “Company”) is a technology-security company incorporated in 1989 as Klever Marketing, Inc. (“Klever”). Its’ wholly-owned subsidiary, DarkPulse Technologies Inc. (“DPTI”), originally started as a technology spinout from the University of New Brunswick, Fredericton, Canada. The Company’s security and monitoring systems will initially be delivered in applications for border security, pipelines, the oil and gas industry and mine safety. Current uses of fiber optic distributed sensor technology have been limited to quasi-static, long-term structural health monitoring due to the time required to obtain the data and its poor precision. The Company’s patented BOTDA dark-pulse sensor technology allows for the monitoring of highly dynamic environments due to its greater resolution and accuracy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s subsidiaries consist of: DarkPulse, Inc., based in New York; Terradata Unmanned PLLC, based in Florida; Optilan India Pvt Ltd based in Navi-Mumbai and Optilan Communications &amp; Security Systems Ltd, based in Ankara Turkey.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Optilan India Pvt Ltd, operating in India, provides project engineering &amp; design, system provisioning and contract bid services for the Company globally. Optilan Communications &amp; Security Systems Ltd, provides project engineering &amp; design, system provisioning and contract bid services for the Company throughout Europe.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">DarkPulse Manufacturing Inc., based in Arizona (formerly TJM Electronics West, Inc.), is no longer providing products or services as a result of the Company’s relationship with Sanmina Corporation who is handling both the design and manufacturing of the Company’s patented hardware.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Remote Intelligence, LLC and Wildlife Specialists, LLC are no longer providing services as a result of redundant service offerings that are now being offered by TerraData Unmanned.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Liquidation/winding up of Optilan (UK) Limited</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On May 3, 2023, Eversheds Sutherland (International) LLP, a creditor of Optilan (UK) Limited, filed a petition to wind up (“Winding up Petition”) Optilan (UK) Limited, a wholly owned subsidiary of the Company’s Subsidiary, Optilan HoldCo 3 Limited, and the matter was due to be heard in the Portsmouth Combined Court Centre on June 28, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On June 28, 2023, the High Court of Justice in the United Kingdom issued a winding-up order for the liquidation and winding up of the affairs of Optilan (UK) Limited (“Optilan Liquidation”). In conjunction with the order, the court appointed the Official Receiver’s Office (“OR”) to take the appointment as liquidator of Optilan (UK) Limited and take control of Optilan (UK) Limited’s assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">At the same time the court appointed the OR to take the appointment as liquidator of Optilan (UK) Limited. The OR has taken control of Optilan (UK) Limited’s assets. To date the ORs Office has initiated contact with Optilan but we still wait to receive details of the individual who will be taking the role of OR.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On July 3, 2023, Optilan (UK) Limited received a letter from The Insolvency Service, an executive agency sponsored by the Department for Business and Trade located in the U.K. Pursuant to the letter of The Insolvency Services, the Company was required to provide information relating to Optilan (UK) Limited to the Official Receiver’s Office (a government body of Plymouth, the United Kingdom) and attend an interview with staff of the Official Receiver’s Office to review the prospect of recovering the assets of Optilan (UK) Limited for the benefit of creditors. The interview occurred July 18, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company is an Unsecured creditor of Optilan (UK) Limited and is at risk of losing any repayment of obligations due from Optilan (UK) Limited because there are several intercompany relationships between the Company and Optilan (UK) Limited, the financial impact of any future claims and liabilities may not be known for several months. The Company has approximately $19.4 million intercompany payables due from Optilan (UK), which will increase the Company liabilities for any obligations not repaid. At the time of this filing the Company is still evaluating the full effects of the winding-up order for liquidation and the material adverse effects it will have on the Company’s continued operations and ability to meet future obligations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On August 9, 2023, Evelyn Partners was appointed Joint Liquidator.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zNeeWcLBFeg2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 2 – <span id="xdx_823_zfLcRcMPzik9">SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">A summary of the significant accounting policies consistently applied in the preparation of the accompanying financial statements are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeAU0Nxq7au7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_860_zWDopMcHBBPg">Basis of Presentation and Principles of Consolidation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”). The consolidated financial statements of the Company include the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluates its relationships with other entities to identify whether they are variable interest entities (“VIE”) as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, <i>Consolidation</i> (“ASC 810”), and to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary, then that entity is consolidated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p id="xdx_845_eus-gaap--UseOfEstimates_z6M0oVVh4zW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_869_zkE1UyXqDhz4">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, assumptions used to calculate derivative liabilities, revenue recognition and impairment of long-lived assets. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVuqaFWMHUF5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86D_zNDgTrJz7M6f">Cash</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with high credit quality financial institutions. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. To reduce its risk associated with the failure of such a financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--ReceivablesPolicyTextBlock_zBzM9V5bbLf2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86E_zFu5PdXBKOP5">Accounts Receivable</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Accounts receivable and contract assets include amounts billed to customers under the terms and provisions of the contracts. Most billings are determined based on contractual terms. As is common practice in the industry, the Company classifies all accounts receivable and contract assets, including retainage, as current assets. The contracting cycle for certain long-term contracts may extend beyond one year, and accordingly, collection of retainage on those contracts may extend beyond one year. Contract assets include amounts billed to customers under retention provisions in construction contracts. Such provisions are standard in the Company’s industry and usually allow for a portion of progress billings on the contract price, typically 5-10%, to be withheld by the customer until after the Company has completed work on the project. Billings for such retention balances at each balance sheet date are finalized and collected after project completion. Generally, unbilled amounts will be billed and collected within one year. The Company determined that there are no material amounts due past one year and no material amounts billed but not expected to be collected within one year. Also, the Company adopted ASU 2016-13 in January 2023 and the adoption did not have a material impact on the Company’s consolidated financial statements and related disclosures for the year ended December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Each month, the Company reviews its receivables on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived collection issues. Any balances that are eventually deemed uncollectible are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2025 and 2024, the Company determined that the allowance for doubtful accounts was $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20251231_zlBWM3u2aPQ3" title="Allowance for doubtful accounts">37,295</span> and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20241231_zSJbh3Q2RVg9" title="Allowance for doubtful accounts">5,458</span>, respectively. The allowance pertaining to Optilan UK was derecognized upon the Optilan Liquidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the year December 31, 2025 the Company recorded bad debt expense related to certain customer accounts based on specific identification. This included a full write-off of $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20250101__20251231__dei--LegalEntityAxis__custom--CarebournMember_zBkNhNYe7irj">367,693</span> for the Carebourn account deemed uncollectible and a partial write-off of $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20250101__20251231__srt--CounterpartyNameAxis__custom--OtherAccountsMember_zCQS80tjYuIi">206,024</span> (representing approximately 50% of the outstanding balance of $412,048) based on management’s assessment of collectability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Accounts receivable includes retainage amounts for the portion of the contract price earned by us for work performed but held for payment by the customer as a form of security until we reach certain construction milestones or complete the project. As of December 31, 2025 and 2024, retainage receivable was $<span id="xdx_900_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20251231_zP2nFJpkkBEh" title="Retainage receivable">0</span> and $<span id="xdx_907_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20241231_zdz6mACuc3Ce" title="Retainage receivable">0</span>, respectively. The retainage pertaining to Optilan UK was derecognized upon the Optilan Liquidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zuzDdoJUSkj9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_869_zxt6cZY2osF3">Foreign Currency Translation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s reporting currency is US Dollars. The accounts of one of the Company’s subsidiaries is maintained using the appropriate local currency, British Pound (“GBP”) as the functional currency, as well as the Turkish lira, Emiraes Dirham, and Indian Rupee. The accounts of one of the Company’s subsidiaries is maintained using the appropriate local currency, Canadian Dollar (“CAD”) as the functional currency. All assets and liabilities are translated into U.S. Dollars at balance sheet date, shareholders’ equity is translated at historical rates and revenue and expense accounts are translated at the average exchange rate for the year or the reporting period. The translation adjustments are reported as a separate component of stockholders’ equity, captioned as accumulated other comprehensive (loss) gain. Transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the statements of operations as foreign currency exchange variance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The relevant translation rates are as follows: for the year ended December 31, 2025 a closing rate at <span id="xdx_903_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--GBP_zdjsdOv8KuMl" title="Foreign currency translation closing rates">1.3448</span> US$: GBP, average rate at <span id="xdx_904_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--GBP_zmwD4tdJZag" title="Foreign currency translation average rates">1.0144</span> US$:GBP and a closing rate at<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--CAD_zdCoi8BDVgge" title="Foreign currency translation rates"> .7286</span> US$:CAD, average rate at <span id="xdx_909_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--CAD_zks4vGQNreLj" title="Foreign currency translation average rates">.7153</span> US$:CAD, a closing rate at <span id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--AED_zylurwAObRa5" title="Foreign currency translation closing rates">.2723</span> US$: AED, average rate at <span id="xdx_902_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--AED_zjsVtyaxtqfh" title="Foreign currency translation average rates">.2723</span> US$: AED, a closing rate at <span id="xdx_90A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--INR_zRNPU0vKsWz4" title="Foreign currency translation rates">.0116</span> US$: INR, average rate at <span id="xdx_904_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--INR_zJkg7p6JgND2" title="Foreign currency translation average rates">.0119</span> US$: INR, a closing rate at <span id="xdx_90E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--TRY_z27LpZD0QIZb" title="Foreign currency translation closing rates">.02328</span> US$: TL, average rate at <span id="xdx_907_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--TRY_zLwrEemED2Tc" title="Foreign currency translation average rates">.02533</span> US$: TL.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The relevant translation rates are as follows: for the year ended December 31, 2024 a closing rate at <span id="xdx_900_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--GBP_zahcLiLmPq04" title="Foreign currency translation closing rates">1.2516</span> US$: GBP, average rate at <span id="xdx_904_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20241231__srt--CurrencyAxis__currency--GBP_zWCUpR5oErMk" title="Foreign currency translation average rates">1.2633</span> US$:GBP and closing rate at <span id="xdx_903_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--CAD_zOUy4XCQvjk3" title="Foreign currency translation rates">1.27</span> US$: CAD, average rate at <span id="xdx_906_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20241231__srt--CurrencyAxis__currency--CAD_zuPMjcLZVj7l" title="Foreign currency translation average rates">.6948</span> US$:CAD, a closing rate at <span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--INR_zxH2SW7sL2ze" title="Foreign currency translation rates">.01169</span> US$: INR, a closing rate at <span id="xdx_906_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--TRY_zX6Y5Y0fKmv7" title="Foreign currency translation closing rates">.02828</span> US$: TL.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.7pt 0pt 5.4pt; text-align: justify"> </p> <p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5QfVBXgFD54" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_865_zbXEgHQsXWx5">Long-Lived Assets and Goodwill</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, <i>Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets.</i> This accounting standard requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Indefinite-lived intangible assets established in connection with business combinations consist of the tradename. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for goodwill and intangible assets in accordance with ASC 350, <i>Intangibles – Goodwill and Other</i>. Goodwill represents the excess of the purchase price of an entity over the estimated fair value of the assets acquired and liabilities assumed. ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. This guidance simplifies the accounting for goodwill impairment by removing Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. The quantitative impairment test calculates any goodwill impairment as the difference between the carrying amount of a reporting unit and its fair value, but not to exceed the carrying amount of goodwill. It is our practice, at a minimum, to perform a qualitative or quantitative goodwill impairment test in the fourth quarter every year. The Company has one reporting unit it evaluates during its impairment test.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zG13mYDrBzFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_867_zIvAfhzjpB1j">Property and Equipment</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Property and equipment are carried at historical cost less accumulated depreciation. Depreciation is based on the estimated service lives of the depreciable assets and is calculated using the straight-line method. Expenditures that increase the value or productive capacity of assets are capitalized. Fully depreciated assets are retained in the property and equipment, and accumulated depreciation accounts until they are removed from service. When property and equipment are retired, sold or otherwise disposed of, the asset’s carrying amount and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. Repairs and maintenance are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated useful lives of property and equipment are generally as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zwPyIZc0fNIj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B6_z5DJ6lpXE757" style="display: none">Schedule of estimated useful lives of property and equipment</span></td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Office furniture and fixtures</td><td style="width: 2%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMtxS3r8qDVh" title="Estimated useful lives">4</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Plant and equipment</td><td> </td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zsr5s28HQwG1" title="Estimated useful lives">4</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaBDM3bYU8J6" title="Estimated useful lives">8</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Leasehold Improvements</td><td> </td> <td style="text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zWEuQ5eWruS4" title="Estimated useful lives">10</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: none; text-align: left">Motor vehicles</td><td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zmuysGY3ezQ6" title="Estimated useful lives">3</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p id="xdx_84C_ecustom--OtherAssetsPolicyPolicyTextBlock_zqVFyK9rdU2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other Assets, Net</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other assets, net consist primarily of deposits and other non-current assets that do not meet the criteria for separate presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, other assets included a $<span id="xdx_905_eus-gaap--DepositAssets_iI_c20251231__us-gaap--TransactionTypeAxis__custom--JointVentureTransactionMember_zsw09a7V0Yoi">100,000</span> deposit related to a proposed joint venture transaction. During the year, the Company evaluated the recoverability of the deposit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on managements assessment, including the status of negotiations and the absence of a completed transaction, the Company determined that the deposit was not recoverable and recorded an impairment charge of $<span id="xdx_90E_eus-gaap--AssetImpairmentCharges_c20250101__20251231__us-gaap--TransactionTypeAxis__custom--JointVentureTransactionMember_zAg8dtnnnyF5">100,000</span> within operating expenses for the year ended December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other assets are reviewed for impairment whenever events of changes in circumstances indicate that their carrying amounts may not be recoverable. Any identified impairment losses are recognized in the period incurred. Other assets are presented net of any impairment charges.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zTF1M4KTeE2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86C_zXihAbQGJVW8">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s revenues are generated primarily from the sale of our services, which consist primarily of advanced technology solutions for integrated communications and security systems, as well as habitat management. The Company’s sales of products are primarily generated from our TJM subsidiaries. Sales of products and services are separate from one another. At contract inception, we assess the goods and services promised in the contract with customers and identify a performance obligation for each. To determine the performance obligation, we consider all products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the amount of consideration expected to be received in exchange for transferring goods and services. We recognize service revenues as the performance obligations are met, which is generally as milestones are satisfied over time. We generally recognize product revenues at the time of shipment, provided that all other revenue recognition criteria have been met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, we perform the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy a performance obligation. The five-step model is applied to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services transferred to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize revenue in the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers each individual sale of service contract to be its own performance obligation. Services in the contract are highly interdependent and interrelated, and the successful completion of each milestone is necessary for the overall success of the contract. Therefore, each milestone is not separately identifiable from other promises in the contract, and not distinct and ultimately not individual performance obligations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company records revenue over time using the input measure as it is the most faithful depiction of an entity’s performance because it directly measures the value of the goods and services transferred to the customer. The Company utilizes the Right to Invoice for these contracts, as the pricing structure is based on various milestones that are specified in the contract. These milestones include Construction Phase Plan, Start of the construction phase, installation phase, site surveys, fiber splicing, recoveries, and closeouts. There are specified payments associated with these milestones in the contract, and the value allocated is commensurate with work done. In the event that there are advances such as upfront retainers and not based on the value, those are recorded as contract liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In accordance with ASU No. 2016-12, <i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedient</i>, which is to (1) clarify the objective of the collectability criterion for applying paragraph 606-10-25-7; (2) permit an entity to exclude amounts collected from customers for all sales (and other similar) taxes from the transaction price; (3) specify that the measurement date for noncash consideration is contract inception; (4) provide a practical expedient that permits an entity to reflect the aggregate effect of all modifications that occur before the beginning of the earliest period presented when identifying the satisfied and unsatisfied performance obligations, determining the transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations; (5) clarify that a completed contract for purposes of transition is a contract for which all (or substantially all) of the revenue was recognized under legacy GAAP before the date of initial application, and (6) clarify that an entity that retrospectively applies the guidance in Topic 606 to each prior reporting period is not required to disclose the effect of the accounting change for the period of adoption. The amendments of this ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. There was no impact as a result of adopting this ASU on the financial statements and related disclosures. Based on the terms and conditions of the product arrangements, the Company believes that its products and services can be accounted for separately as its products and services have value to the Company’s customers on a stand-alone basis. When a transaction involves more than one product or service, revenue is allocated to each deliverable based on its relative fair value; otherwise, revenue is recognized as products are delivered or as services are provided over the term of the customer contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--CostOfSalesPolicyTextBlock_zXKqyBxg13mg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86D_zDTUvxku7YYa">Cost of Revenues</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Cost of revenues consists primarily of materials and overhead costs incurred internally and amounts incurred to contract manufacturers to produce our products, airtime and other implementation costs incurred to install our products and train customer personnel, and customer service and third-party original equipment manufacturer costs to provide continuing support to our customers. Cost of revenues also includes direct labor attributable to revenue service arrangements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zGtM4OtCVA2c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_861_zTJmjXV3lt18">Concentration of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any losses related to its cash and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. As of December 31, 2025, one customer accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zwFnZH6aoOb2" title="Concentration risk, percentage">32</span>% of gross accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zHvmlBuG5UV7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86F_zYamGCm0zi8k">Leases</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for its leases under ASC 842, <i>Leases</i>. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right of use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company’s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right of use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right of use asset result in straight-line rent expense over the lease term. For finance leases, interest on the lease liability and the amortization of the right of use asset results in front-loaded expense over the lease term. Variable lease expenses are recorded when incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In calculating the right of use asset and lease liability, the Company has elected to combine lease and non-lease components. The Company excludes short-term leases having initial terms of 12 months or less from the new guidance as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_z3SJLPRXdvwb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_865_zbbm4wbvQZH8">Derivative Financial Instruments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a lattice model, in accordance with ASC 815-15<i>, Derivative and Hedging,</i> to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months after the balance sheet date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zv1HxVrI6X3e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_861_zMo1rN1CEMal">Fair Value of Financial Instruments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, <i>Fair Value Measurements and Disclosures.</i> As defined in FASB ASC 820, the fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 established a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement) as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.35pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s derivative liability is a Level 3 liability measured at fair value on a recurring basis. See Note 11.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_848_eus-gaap--EquityMethodInvestmentsPolicy_zJv7XYALtxMl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_866_z2IVXjM4c1ul">Equity Investments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company uses the equity method to account for investments in which it has the ability to exercise significant influence over the investee’s operating and financial policies, or in which its holds a partnership or limited liability company interest in an entity with specific ownership accounts, unless it has virtually no influence over the investee’s operating and financial policies. The Company follows the guidance in ASC 323-10-30-2, Joint Ventures, which prescribes the use of the equity method for investments in joint ventures where the Company has significant influence. Equity method investments are recorded at cost and are adjusted to recognize (1) the Company’s share, based on percentage ownership or other contractual basis, of the investee’s net income or loss after the date of investment, (2) amortization of the recorded investment that exceeds the Company’s share of the book value of the investee’s net assets, (3) additional contributions made and dividends received, and (4) impairments resulting from other-than-temporary declines in fair value. Gain (loss) on equity investment includes realized gains or losses upon the sale of the investment and are included as other income (expense) in the consolidated statements of operations and comprehensive (loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Per ASC 323-10-30-2, Joint Ventures are accounted for using the equity method, in which the Company initially records its investment at cost, including transaction costs. Under the equity method, an investment in common stock and in-substance common stock is presented on the balance sheet of an investor as a single amount. However, any difference between the cost of the investment and the underlying equity in net assets of an investee — commonly referred to as a basis difference — should be accounted for as if the investee were a consolidated subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zCuHDNZfeMP2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_864_z3x5VDqj7uw1">Income Taxes</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for income taxes pursuant to the provision of ASC 740-10, (“ASC 740-10”) which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company has adopted ASC 740-10-25, <i>Definition of Settlement</i> which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s U.S. subsidiaries were incorporated in 2017. The Company does not anticipate a tax liability for the years 2025 and 2024, however may be subject to certain penalties. The Company has filed tax returns in Canada for the year ended December 31, 2018, and they are still subject to audit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p id="xdx_848_ecustom--NonControllingInterestsPolicyTextBlock_zrgbuwi4bm88" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_866_zQ8f2xHNfxG3">Non-controlling Interests</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Non-controlling interests are classified as a separate component of equity in the Company’s consolidated balance sheets and statements of changes in stockholders’ equity. Net income (loss) and comprehensive income (loss) attributable to non-controlling interests are reflected separately from consolidated net income (loss) and comprehensive income (loss) in the consolidated statements of comprehensive income (loss) and statements of changes in stockholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.4pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests. In addition, when a subsidiary is deconsolidated, any retained non-controlling equity investment in the former subsidiary will be initially measured at fair value and the difference between the carrying value and fair value of the retained interest will be recorded as a gain or loss. The Company has non-controlling interests via its subsidiaries TerraData, Remote Intelligence and Wildlife Specialists.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the years ended December 31, 2025 and 2024, the Company recorded a loss of $<span id="xdx_90F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_c20250101__20251231_zYv8tBEuFXSi" title="Net loss attributable to non-controlling interests">(41,232)</span> and $<span id="xdx_90E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_c20240101__20241231_zFVyS4afO478" title="Net loss attributable to non-controlling interests">10,404</span> respectively, attributable to non-controlling interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_842_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zhzu5mGBIete" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_869_zCqsAzKBVuik">Comprehensive Loss</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Comprehensive loss includes net loss well as other changes in stockholders’ equity that result from transactions and economic events other than those with stockholders. During the years ended December 31, 2025 and 2024, the Company’s only element of other comprehensive loss was foreign currency translation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84F_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zPvXshCkxHjf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86B_zgcTem8WcJCa">Stock-based Compensation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the consolidated financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Pursuant to ASC Topic 718, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date. Further, ASC Topic 718, provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718, such as the repricing of share options, which would revalue those options and the accounting for the cancellation of an equity award whether a replacement award or other valuable consideration is issued in conjunction with the cancellation. If not, the cancellation is viewed as a replacement and not a modification, with a repurchase price of $0<i>.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zwA9xD4XtpB8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86E_zx2zmiKbBQAi">Loss Per Common Share</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for earnings per share pursuant to ASC 260, <i>Earnings per Share</i>, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. In periods where the Company has a net loss, all dilutive securities are excluded. Potentially dilutive items outstanding as of December 31, 2025 and 2024 are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zCahNTXCzzme" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td style="text-decoration: none; text-align: left"><span id="xdx_8BA_zPY7hVPb0r48" style="display: none">Schedule of anti-dilutive securities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Years Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; width: 66%; text-align: left">Convertible notes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zldj0bPRAHF2" style="width: 13%; text-align: right" title="Antidilutive shares">0</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zZceEcQZlaT4" style="width: 13%; text-align: right" title="Antidilutive shares">0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: none; padding-bottom: 1pt; text-align: left">Series D preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesDPreferredStockMember_zaJOPUf10PEg" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesDPreferredStockMember_zp9V2SNj2UC9" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zD4G28AE1teh" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zhLf7WCS43k4" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZbxuW7z7Q53" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_868_z0BDVD66ind5">Recently Issued Accounting Pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 1, 2023, the Company adopted ASU 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASC 326).</i> This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. The Company adopted this new guidance on January 1, 2023 and the adoption did not have a material impact on the Company’s consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.4pt; text-align: justify"> </p> <p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zeAU0Nxq7au7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_860_zWDopMcHBBPg">Basis of Presentation and Principles of Consolidation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”). The consolidated financial statements of the Company include the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluates its relationships with other entities to identify whether they are variable interest entities (“VIE”) as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, <i>Consolidation</i> (“ASC 810”), and to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary, then that entity is consolidated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p id="xdx_845_eus-gaap--UseOfEstimates_z6M0oVVh4zW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_869_zkE1UyXqDhz4">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, assumptions used to calculate derivative liabilities, revenue recognition and impairment of long-lived assets. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVuqaFWMHUF5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86D_zNDgTrJz7M6f">Cash</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with high credit quality financial institutions. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. To reduce its risk associated with the failure of such a financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--ReceivablesPolicyTextBlock_zBzM9V5bbLf2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86E_zFu5PdXBKOP5">Accounts Receivable</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Accounts receivable and contract assets include amounts billed to customers under the terms and provisions of the contracts. Most billings are determined based on contractual terms. As is common practice in the industry, the Company classifies all accounts receivable and contract assets, including retainage, as current assets. The contracting cycle for certain long-term contracts may extend beyond one year, and accordingly, collection of retainage on those contracts may extend beyond one year. Contract assets include amounts billed to customers under retention provisions in construction contracts. Such provisions are standard in the Company’s industry and usually allow for a portion of progress billings on the contract price, typically 5-10%, to be withheld by the customer until after the Company has completed work on the project. Billings for such retention balances at each balance sheet date are finalized and collected after project completion. Generally, unbilled amounts will be billed and collected within one year. The Company determined that there are no material amounts due past one year and no material amounts billed but not expected to be collected within one year. Also, the Company adopted ASU 2016-13 in January 2023 and the adoption did not have a material impact on the Company’s consolidated financial statements and related disclosures for the year ended December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Each month, the Company reviews its receivables on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived collection issues. Any balances that are eventually deemed uncollectible are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December 31, 2025 and 2024, the Company determined that the allowance for doubtful accounts was $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20251231_zlBWM3u2aPQ3" title="Allowance for doubtful accounts">37,295</span> and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20241231_zSJbh3Q2RVg9" title="Allowance for doubtful accounts">5,458</span>, respectively. The allowance pertaining to Optilan UK was derecognized upon the Optilan Liquidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the year December 31, 2025 the Company recorded bad debt expense related to certain customer accounts based on specific identification. This included a full write-off of $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20250101__20251231__dei--LegalEntityAxis__custom--CarebournMember_zBkNhNYe7irj">367,693</span> for the Carebourn account deemed uncollectible and a partial write-off of $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20250101__20251231__srt--CounterpartyNameAxis__custom--OtherAccountsMember_zCQS80tjYuIi">206,024</span> (representing approximately 50% of the outstanding balance of $412,048) based on management’s assessment of collectability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Accounts receivable includes retainage amounts for the portion of the contract price earned by us for work performed but held for payment by the customer as a form of security until we reach certain construction milestones or complete the project. As of December 31, 2025 and 2024, retainage receivable was $<span id="xdx_900_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20251231_zP2nFJpkkBEh" title="Retainage receivable">0</span> and $<span id="xdx_907_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_pp0p0_c20241231_zdz6mACuc3Ce" title="Retainage receivable">0</span>, respectively. The retainage pertaining to Optilan UK was derecognized upon the Optilan Liquidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 37295 5458 367693 206024 0 0 <p id="xdx_84D_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zuzDdoJUSkj9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_869_zxt6cZY2osF3">Foreign Currency Translation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s reporting currency is US Dollars. The accounts of one of the Company’s subsidiaries is maintained using the appropriate local currency, British Pound (“GBP”) as the functional currency, as well as the Turkish lira, Emiraes Dirham, and Indian Rupee. The accounts of one of the Company’s subsidiaries is maintained using the appropriate local currency, Canadian Dollar (“CAD”) as the functional currency. All assets and liabilities are translated into U.S. Dollars at balance sheet date, shareholders’ equity is translated at historical rates and revenue and expense accounts are translated at the average exchange rate for the year or the reporting period. The translation adjustments are reported as a separate component of stockholders’ equity, captioned as accumulated other comprehensive (loss) gain. Transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the statements of operations as foreign currency exchange variance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The relevant translation rates are as follows: for the year ended December 31, 2025 a closing rate at <span id="xdx_903_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--GBP_zdjsdOv8KuMl" title="Foreign currency translation closing rates">1.3448</span> US$: GBP, average rate at <span id="xdx_904_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--GBP_zmwD4tdJZag" title="Foreign currency translation average rates">1.0144</span> US$:GBP and a closing rate at<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--CAD_zdCoi8BDVgge" title="Foreign currency translation rates"> .7286</span> US$:CAD, average rate at <span id="xdx_909_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--CAD_zks4vGQNreLj" title="Foreign currency translation average rates">.7153</span> US$:CAD, a closing rate at <span id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--AED_zylurwAObRa5" title="Foreign currency translation closing rates">.2723</span> US$: AED, average rate at <span id="xdx_902_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--AED_zjsVtyaxtqfh" title="Foreign currency translation average rates">.2723</span> US$: AED, a closing rate at <span id="xdx_90A_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--INR_zRNPU0vKsWz4" title="Foreign currency translation rates">.0116</span> US$: INR, average rate at <span id="xdx_904_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--INR_zJkg7p6JgND2" title="Foreign currency translation average rates">.0119</span> US$: INR, a closing rate at <span id="xdx_90E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20251231__srt--CurrencyAxis__currency--TRY_z27LpZD0QIZb" title="Foreign currency translation closing rates">.02328</span> US$: TL, average rate at <span id="xdx_907_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20251231__srt--CurrencyAxis__currency--TRY_zLwrEemED2Tc" title="Foreign currency translation average rates">.02533</span> US$: TL.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The relevant translation rates are as follows: for the year ended December 31, 2024 a closing rate at <span id="xdx_900_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--GBP_zahcLiLmPq04" title="Foreign currency translation closing rates">1.2516</span> US$: GBP, average rate at <span id="xdx_904_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20241231__srt--CurrencyAxis__currency--GBP_zWCUpR5oErMk" title="Foreign currency translation average rates">1.2633</span> US$:GBP and closing rate at <span id="xdx_903_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--CAD_zOUy4XCQvjk3" title="Foreign currency translation rates">1.27</span> US$: CAD, average rate at <span id="xdx_906_ecustom--ForeignCurrencyExchangeRateTranslation2_iI_c20241231__srt--CurrencyAxis__currency--CAD_zuPMjcLZVj7l" title="Foreign currency translation average rates">.6948</span> US$:CAD, a closing rate at <span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--INR_zxH2SW7sL2ze" title="Foreign currency translation rates">.01169</span> US$: INR, a closing rate at <span id="xdx_906_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20241231__srt--CurrencyAxis__currency--TRY_zX6Y5Y0fKmv7" title="Foreign currency translation closing rates">.02828</span> US$: TL.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.7pt 0pt 5.4pt; text-align: justify"> </p> 1.3448 1.0144 0.7286 0.7153 0.2723 0.2723 0.0116 0.0119 0.02328 0.02533 1.2516 1.2633 1.27 0.6948 0.01169 0.02828 <p id="xdx_847_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z5QfVBXgFD54" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_865_zbXEgHQsXWx5">Long-Lived Assets and Goodwill</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, <i>Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets.</i> This accounting standard requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Indefinite-lived intangible assets established in connection with business combinations consist of the tradename. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for goodwill and intangible assets in accordance with ASC 350, <i>Intangibles – Goodwill and Other</i>. Goodwill represents the excess of the purchase price of an entity over the estimated fair value of the assets acquired and liabilities assumed. ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. This guidance simplifies the accounting for goodwill impairment by removing Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. The quantitative impairment test calculates any goodwill impairment as the difference between the carrying amount of a reporting unit and its fair value, but not to exceed the carrying amount of goodwill. It is our practice, at a minimum, to perform a qualitative or quantitative goodwill impairment test in the fourth quarter every year. The Company has one reporting unit it evaluates during its impairment test.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zG13mYDrBzFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_867_zIvAfhzjpB1j">Property and Equipment</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Property and equipment are carried at historical cost less accumulated depreciation. Depreciation is based on the estimated service lives of the depreciable assets and is calculated using the straight-line method. Expenditures that increase the value or productive capacity of assets are capitalized. Fully depreciated assets are retained in the property and equipment, and accumulated depreciation accounts until they are removed from service. When property and equipment are retired, sold or otherwise disposed of, the asset’s carrying amount and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. Repairs and maintenance are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated useful lives of property and equipment are generally as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zwPyIZc0fNIj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B6_z5DJ6lpXE757" style="display: none">Schedule of estimated useful lives of property and equipment</span></td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Office furniture and fixtures</td><td style="width: 2%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMtxS3r8qDVh" title="Estimated useful lives">4</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Plant and equipment</td><td> </td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zsr5s28HQwG1" title="Estimated useful lives">4</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaBDM3bYU8J6" title="Estimated useful lives">8</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Leasehold Improvements</td><td> </td> <td style="text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zWEuQ5eWruS4" title="Estimated useful lives">10</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: none; text-align: left">Motor vehicles</td><td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zmuysGY3ezQ6" title="Estimated useful lives">3</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--ScheduleOfEstimatedUsefulLivesTableTextBlock_zwPyIZc0fNIj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B6_z5DJ6lpXE757" style="display: none">Schedule of estimated useful lives of property and equipment</span></td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Office furniture and fixtures</td><td style="width: 2%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMtxS3r8qDVh" title="Estimated useful lives">4</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Plant and equipment</td><td> </td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zsr5s28HQwG1" title="Estimated useful lives">4</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaBDM3bYU8J6" title="Estimated useful lives">8</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Leasehold Improvements</td><td> </td> <td style="text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zWEuQ5eWruS4" title="Estimated useful lives">10</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: none; text-align: left">Motor vehicles</td><td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MotorVehiclesMember_zmuysGY3ezQ6" title="Estimated useful lives">3</span></td></tr> </table> P4Y P4Y P8Y P10Y P3Y <p id="xdx_84C_ecustom--OtherAssetsPolicyPolicyTextBlock_zqVFyK9rdU2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other Assets, Net</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other assets, net consist primarily of deposits and other non-current assets that do not meet the criteria for separate presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, other assets included a $<span id="xdx_905_eus-gaap--DepositAssets_iI_c20251231__us-gaap--TransactionTypeAxis__custom--JointVentureTransactionMember_zsw09a7V0Yoi">100,000</span> deposit related to a proposed joint venture transaction. During the year, the Company evaluated the recoverability of the deposit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on managements assessment, including the status of negotiations and the absence of a completed transaction, the Company determined that the deposit was not recoverable and recorded an impairment charge of $<span id="xdx_90E_eus-gaap--AssetImpairmentCharges_c20250101__20251231__us-gaap--TransactionTypeAxis__custom--JointVentureTransactionMember_zAg8dtnnnyF5">100,000</span> within operating expenses for the year ended December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other assets are reviewed for impairment whenever events of changes in circumstances indicate that their carrying amounts may not be recoverable. Any identified impairment losses are recognized in the period incurred. Other assets are presented net of any impairment charges.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 100000 100000 <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zTF1M4KTeE2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86C_zXihAbQGJVW8">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s revenues are generated primarily from the sale of our services, which consist primarily of advanced technology solutions for integrated communications and security systems, as well as habitat management. The Company’s sales of products are primarily generated from our TJM subsidiaries. Sales of products and services are separate from one another. At contract inception, we assess the goods and services promised in the contract with customers and identify a performance obligation for each. To determine the performance obligation, we consider all products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the amount of consideration expected to be received in exchange for transferring goods and services. We recognize service revenues as the performance obligations are met, which is generally as milestones are satisfied over time. We generally recognize product revenues at the time of shipment, provided that all other revenue recognition criteria have been met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, we perform the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy a performance obligation. The five-step model is applied to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services transferred to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize revenue in the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers each individual sale of service contract to be its own performance obligation. Services in the contract are highly interdependent and interrelated, and the successful completion of each milestone is necessary for the overall success of the contract. Therefore, each milestone is not separately identifiable from other promises in the contract, and not distinct and ultimately not individual performance obligations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company records revenue over time using the input measure as it is the most faithful depiction of an entity’s performance because it directly measures the value of the goods and services transferred to the customer. The Company utilizes the Right to Invoice for these contracts, as the pricing structure is based on various milestones that are specified in the contract. These milestones include Construction Phase Plan, Start of the construction phase, installation phase, site surveys, fiber splicing, recoveries, and closeouts. There are specified payments associated with these milestones in the contract, and the value allocated is commensurate with work done. In the event that there are advances such as upfront retainers and not based on the value, those are recorded as contract liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In accordance with ASU No. 2016-12, <i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedient</i>, which is to (1) clarify the objective of the collectability criterion for applying paragraph 606-10-25-7; (2) permit an entity to exclude amounts collected from customers for all sales (and other similar) taxes from the transaction price; (3) specify that the measurement date for noncash consideration is contract inception; (4) provide a practical expedient that permits an entity to reflect the aggregate effect of all modifications that occur before the beginning of the earliest period presented when identifying the satisfied and unsatisfied performance obligations, determining the transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations; (5) clarify that a completed contract for purposes of transition is a contract for which all (or substantially all) of the revenue was recognized under legacy GAAP before the date of initial application, and (6) clarify that an entity that retrospectively applies the guidance in Topic 606 to each prior reporting period is not required to disclose the effect of the accounting change for the period of adoption. The amendments of this ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. There was no impact as a result of adopting this ASU on the financial statements and related disclosures. Based on the terms and conditions of the product arrangements, the Company believes that its products and services can be accounted for separately as its products and services have value to the Company’s customers on a stand-alone basis. When a transaction involves more than one product or service, revenue is allocated to each deliverable based on its relative fair value; otherwise, revenue is recognized as products are delivered or as services are provided over the term of the customer contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--CostOfSalesPolicyTextBlock_zXKqyBxg13mg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86D_zDTUvxku7YYa">Cost of Revenues</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Cost of revenues consists primarily of materials and overhead costs incurred internally and amounts incurred to contract manufacturers to produce our products, airtime and other implementation costs incurred to install our products and train customer personnel, and customer service and third-party original equipment manufacturer costs to provide continuing support to our customers. Cost of revenues also includes direct labor attributable to revenue service arrangements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zGtM4OtCVA2c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_861_zTJmjXV3lt18">Concentration of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any losses related to its cash and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. As of December 31, 2025, one customer accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20250101__20251231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zwFnZH6aoOb2" title="Concentration risk, percentage">32</span>% of gross accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> 0.32 <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zHvmlBuG5UV7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86F_zYamGCm0zi8k">Leases</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for its leases under ASC 842, <i>Leases</i>. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the consolidated balance sheet as both a right of use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company’s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right of use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right of use asset result in straight-line rent expense over the lease term. For finance leases, interest on the lease liability and the amortization of the right of use asset results in front-loaded expense over the lease term. Variable lease expenses are recorded when incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In calculating the right of use asset and lease liability, the Company has elected to combine lease and non-lease components. The Company excludes short-term leases having initial terms of 12 months or less from the new guidance as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--DerivativesReportingOfDerivativeActivity_z3SJLPRXdvwb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_865_zbbm4wbvQZH8">Derivative Financial Instruments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a lattice model, in accordance with ASC 815-15<i>, Derivative and Hedging,</i> to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months after the balance sheet date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zv1HxVrI6X3e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_861_zMo1rN1CEMal">Fair Value of Financial Instruments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, <i>Fair Value Measurements and Disclosures.</i> As defined in FASB ASC 820, the fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 established a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement) as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.35pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s derivative liability is a Level 3 liability measured at fair value on a recurring basis. See Note 11.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_848_eus-gaap--EquityMethodInvestmentsPolicy_zJv7XYALtxMl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_866_z2IVXjM4c1ul">Equity Investments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company uses the equity method to account for investments in which it has the ability to exercise significant influence over the investee’s operating and financial policies, or in which its holds a partnership or limited liability company interest in an entity with specific ownership accounts, unless it has virtually no influence over the investee’s operating and financial policies. The Company follows the guidance in ASC 323-10-30-2, Joint Ventures, which prescribes the use of the equity method for investments in joint ventures where the Company has significant influence. Equity method investments are recorded at cost and are adjusted to recognize (1) the Company’s share, based on percentage ownership or other contractual basis, of the investee’s net income or loss after the date of investment, (2) amortization of the recorded investment that exceeds the Company’s share of the book value of the investee’s net assets, (3) additional contributions made and dividends received, and (4) impairments resulting from other-than-temporary declines in fair value. Gain (loss) on equity investment includes realized gains or losses upon the sale of the investment and are included as other income (expense) in the consolidated statements of operations and comprehensive (loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Per ASC 323-10-30-2, Joint Ventures are accounted for using the equity method, in which the Company initially records its investment at cost, including transaction costs. Under the equity method, an investment in common stock and in-substance common stock is presented on the balance sheet of an investor as a single amount. However, any difference between the cost of the investment and the underlying equity in net assets of an investee — commonly referred to as a basis difference — should be accounted for as if the investee were a consolidated subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zCuHDNZfeMP2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_864_z3x5VDqj7uw1">Income Taxes</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for income taxes pursuant to the provision of ASC 740-10, (“ASC 740-10”) which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Tax positions that meet the more likely than not recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company has adopted ASC 740-10-25, <i>Definition of Settlement</i> which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s U.S. subsidiaries were incorporated in 2017. The Company does not anticipate a tax liability for the years 2025 and 2024, however may be subject to certain penalties. The Company has filed tax returns in Canada for the year ended December 31, 2018, and they are still subject to audit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p id="xdx_848_ecustom--NonControllingInterestsPolicyTextBlock_zrgbuwi4bm88" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_866_zQ8f2xHNfxG3">Non-controlling Interests</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Non-controlling interests are classified as a separate component of equity in the Company’s consolidated balance sheets and statements of changes in stockholders’ equity. Net income (loss) and comprehensive income (loss) attributable to non-controlling interests are reflected separately from consolidated net income (loss) and comprehensive income (loss) in the consolidated statements of comprehensive income (loss) and statements of changes in stockholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.4pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests. In addition, when a subsidiary is deconsolidated, any retained non-controlling equity investment in the former subsidiary will be initially measured at fair value and the difference between the carrying value and fair value of the retained interest will be recorded as a gain or loss. The Company has non-controlling interests via its subsidiaries TerraData, Remote Intelligence and Wildlife Specialists.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the years ended December 31, 2025 and 2024, the Company recorded a loss of $<span id="xdx_90F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_c20250101__20251231_zYv8tBEuFXSi" title="Net loss attributable to non-controlling interests">(41,232)</span> and $<span id="xdx_90E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_c20240101__20241231_zFVyS4afO478" title="Net loss attributable to non-controlling interests">10,404</span> respectively, attributable to non-controlling interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 41232 -10404 <p id="xdx_842_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zhzu5mGBIete" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_869_zCqsAzKBVuik">Comprehensive Loss</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Comprehensive loss includes net loss well as other changes in stockholders’ equity that result from transactions and economic events other than those with stockholders. During the years ended December 31, 2025 and 2024, the Company’s only element of other comprehensive loss was foreign currency translation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84F_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zPvXshCkxHjf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86B_zgcTem8WcJCa">Stock-based Compensation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the consolidated financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Pursuant to ASC Topic 718, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date. Further, ASC Topic 718, provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718, such as the repricing of share options, which would revalue those options and the accounting for the cancellation of an equity award whether a replacement award or other valuable consideration is issued in conjunction with the cancellation. If not, the cancellation is viewed as a replacement and not a modification, with a repurchase price of $0<i>.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_zwA9xD4XtpB8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_86E_zx2zmiKbBQAi">Loss Per Common Share</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company accounts for earnings per share pursuant to ASC 260, <i>Earnings per Share</i>, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. In periods where the Company has a net loss, all dilutive securities are excluded. Potentially dilutive items outstanding as of December 31, 2025 and 2024 are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zCahNTXCzzme" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td style="text-decoration: none; text-align: left"><span id="xdx_8BA_zPY7hVPb0r48" style="display: none">Schedule of anti-dilutive securities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Years Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; width: 66%; text-align: left">Convertible notes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zldj0bPRAHF2" style="width: 13%; text-align: right" title="Antidilutive shares">0</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zZceEcQZlaT4" style="width: 13%; text-align: right" title="Antidilutive shares">0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: none; padding-bottom: 1pt; text-align: left">Series D preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesDPreferredStockMember_zaJOPUf10PEg" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesDPreferredStockMember_zp9V2SNj2UC9" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zD4G28AE1teh" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zhLf7WCS43k4" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zCahNTXCzzme" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td style="text-decoration: none; text-align: left"><span id="xdx_8BA_zPY7hVPb0r48" style="display: none">Schedule of anti-dilutive securities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Years Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; width: 66%; text-align: left">Convertible notes</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zldj0bPRAHF2" style="width: 13%; text-align: right" title="Antidilutive shares">0</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zZceEcQZlaT4" style="width: 13%; text-align: right" title="Antidilutive shares">0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: none; padding-bottom: 1pt; text-align: left">Series D preferred stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesDPreferredStockMember_zaJOPUf10PEg" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesDPreferredStockMember_zp9V2SNj2UC9" style="border-bottom: Black 1pt solid; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zD4G28AE1teh" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zhLf7WCS43k4" style="border-bottom: Black 2.5pt double; text-align: right" title="Antidilutive shares">176,470</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 0 176470 176470 176470 176470 <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZbxuW7z7Q53" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span id="xdx_868_z0BDVD66ind5">Recently Issued Accounting Pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 1, 2023, the Company adopted ASU 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASC 326).</i> This standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. The Company adopted this new guidance on January 1, 2023 and the adoption did not have a material impact on the Company’s consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.4pt; text-align: justify"> </p> <p id="xdx_80A_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zsw1T7UmRUI4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 3 – <span id="xdx_829_znejePVRp6D4">LIQUIDITY AND GOING CONCERN</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company generated net losses of $<span id="xdx_907_eus-gaap--ProfitLoss_iN_di_c20250101__20251231_zqihWc67MuZk">2,925,582</span> and $<span id="xdx_909_eus-gaap--ProfitLoss_iN_di_c20240101__20241231_z8zTTmhua9jg">3,893,859</span> during the years ended December 31, 2025 and 2024, respectively, and net cash used in operating activities of $<span id="xdx_900_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20250101__20251231_zZXKwBww46V1">66,483</span> and $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20240101__20241231_zfmrYnjVox59">1,514,351</span>, respectively. As of December 31, 2025, the Company’s current liabilities exceeded its current assets by $<span id="xdx_906_ecustom--WorkingCapital_iI_pp0p0_c20251231_zt4tUHRDK4yk">19,721,196</span> and an accumulated deficit of $<span id="xdx_902_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20251231_z2I3O8yXkkJ7">74,226,493</span>. As of December 31, 2025, the Company had $<span id="xdx_90E_eus-gaap--Cash_pp0p0_c20251231_zCSKxPhkqxMj">62,786</span> of cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company will require additional funding during the next twelve months to finance the growth of its current operations and achieve its strategic objectives. These factors, as well as the uncertain conditions that the Company faces relative to capital raising activities, create substantial doubt as to the Company’s ability to continue as a going concern. The Company is seeking to raise additional capital principally through private placement offerings and is targeting strategic partners in an effort to finalize the development of its products and begin generating revenues. The ability of the Company to continue as a going concern is dependent upon the success of future capital offerings or alternative financing arrangements or expansion of its operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations for twelve months from the issuance date of these consolidated financial statements. However, management cannot make any assurances that such financing will be secured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> -2925582 -3893859 -66483 -1514351 19721196 -74226493 62786 <p id="xdx_80A_eus-gaap--BusinessCombinationDisclosureTextBlock_zjDBPPBoU4z5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 4 – <span id="xdx_82C_zgG1gbuFyMtk">BUSINESS ACQUISITIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Optilan India PVT, Ltd and Optilan Communication &amp; Security Systems, Ltd.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On September 11, 2024, the Company closed a sale agreement with COLIN HARDMAN, CHRISTOPHER ALLEN AND GREGORY ANDREW PALFREY as Joint Liquidators, Optilan (UK) Limited incorporated and registered in England and Wales acting by the Joint Liquidators (Seller), purchasing the right, title and interest of shares in Optilan India, PVT located in Kilpauk, Chennai India and Optilan Communication &amp; Security Systems, Ltd. located in Ankara, Turkey along with the applicable intellectual property rights including (1) the user interface for sensor systems, (2) The “Optilan.com” domain name and continued use of the “@optilan.com” email accounts. The Company agreed to pay $<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_c20240910__20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zv9Gal2kAiY9" title="Intellectual property">65,000</span> USD for both companies and the intellectual property rights.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company has accounted for the purchase using the acquisition method of accounting for business combinations under ASC 805. Accordingly, the purchase price has been allocated to the underlying assets and liabilities in proportion to their respective actual values as of the purchase date. The excess of the consideration transferred over the actual estimated fair values of the net assets acquired was recorded as goodwill. The following table summarizes the acquired assets and assumed liabilities for the actual value of the assets and liabilities recognized at the date of acquisition:</p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_z5F1rD0Maf6g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITIONS (Details - Condensed consolidated balance sheet)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BB_zmyPqxn2gy6g" style="display: none">Schedule of acquired assets and assumed liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Consideration</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Property, Plant &amp; Equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c20240910__20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zycFmqhkW1k1" style="width: 13%; text-align: right" title="Property, Plant &amp; Equipment">22,100</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Shares</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20240910__20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zUqBPeV2iPcd" style="border-bottom: Black 1pt solid; text-align: right" title="Shares">42,900</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationConsiderationTransferred1_c20240910__20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zqJyKynTI6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase price">65,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The allocation of the total purchase price to the tangible and intangible assets acquired and liabilities assumed by DarkPulse based on actual values as of September 11, 2024, and measurement period adjustments resulting from the Optilan India fiscal audit period April 2023 – March 2024 which was completed in December 2024 are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zz1OwcfWhxta" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITIONS (Details - Fair value of assets and liabilities acquisition)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BB_z7GMLsP9n9hf" style="display: none">Schedule of fair value assets acquired and liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-style: italic; text-align: center">(Amounts in US$’s)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.15pt 0pt 7.65pt; text-align: center; text-indent: -0.05pt"><b>Amounts Recognized as of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.45pt 0pt 0; text-align: center"><b>Acquisition Date</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.75pt; text-indent: -13.7pt"><b>Measurement Period</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>Adjustments</b></p></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zkqyAIlrMDQ6" style="width: 13%; text-align: right" title="Cash">1,637</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zBC1tuPxonL1" style="width: 13%; text-align: right" title="Cash">199</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="width: 13%; text-align: right" title="Cash">1,836</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zcdWzFunkV3b" style="text-align: right" title="Accounts receivable">128,392</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Accounts receivable">61,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Accounts receivable">189,732</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zLVyfzOwAHXa" style="text-align: right" title="Other current assets">89,082</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Other current assets">56,455</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Other current assets">145,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property &amp; equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zChmjw1mr94i" style="text-align: right" title="Property &amp; equipment">35,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zrlwIOFN9Iua" style="text-align: right" title="Property &amp; equipment">(2,246</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment_iI_pp0p0_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zO4VgAzTVKrh" style="text-align: right" title="Property &amp; equipment">33,349</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--GoodwillSegement_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zkdU9BLdxez" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill">181,478</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--GoodwillSegement_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_znQKgV09AH1j" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill">(156,563</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--GoodwillSegement_iI_pp0p0_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_z2HHpLHhYSZi" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill">24,770</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsset_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zz5wwjrwK719" style="border-bottom: Black 1pt solid; text-align: right" title="Total assets">436,184</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsset_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zMjv2xZlN349" style="border-bottom: Black 1pt solid; text-align: right" title="Total assets">(40,779</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsset_iI_pp0p0_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_z5SUkoujV0Ue" style="border-bottom: Black 1pt solid; text-align: right" title="Total assets">395,223</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Assumed liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zBes6d4qQB4l" style="text-align: right" title="Assumed liabilities">371,184</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Assumed liabilities">56,755</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Assumed liabilities">314,247</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Gain on acquisition</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pp0p0_di0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zhLZFG8PUpw2" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on acquisition">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pp0p0_di_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zf7UxDxuROea" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on acquisition">(15,976</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pp0p0_di_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zbOqdmBRFNIf" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on acquisition">(15,976</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Consideration for 100% of equity interests</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zDqtoLsYjWga" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration for 100% of equity interests">65,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0_d0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zHlpzQOu9eS7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration for 100% of equity interests">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration for 100% of equity interests">65,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 65000 <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_z5F1rD0Maf6g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITIONS (Details - Condensed consolidated balance sheet)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BB_zmyPqxn2gy6g" style="display: none">Schedule of acquired assets and assumed liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Consideration</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">Property, Plant &amp; Equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_c20240910__20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zycFmqhkW1k1" style="width: 13%; text-align: right" title="Property, Plant &amp; Equipment">22,100</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Shares</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20240910__20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zUqBPeV2iPcd" style="border-bottom: Black 1pt solid; text-align: right" title="Shares">42,900</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationConsiderationTransferred1_c20240910__20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zqJyKynTI6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase price">65,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 22100 42900 65000 <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zz1OwcfWhxta" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS ACQUISITIONS (Details - Fair value of assets and liabilities acquisition)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BB_z7GMLsP9n9hf" style="display: none">Schedule of fair value assets acquired and liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-style: italic; text-align: center">(Amounts in US$’s)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 10.15pt 0pt 7.65pt; text-align: center; text-indent: -0.05pt"><b>Amounts Recognized as of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.45pt 0pt 0; text-align: center"><b>Acquisition Date</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.75pt; text-indent: -13.7pt"><b>Measurement Period</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>Adjustments</b></p></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zkqyAIlrMDQ6" style="width: 13%; text-align: right" title="Cash">1,637</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zBC1tuPxonL1" style="width: 13%; text-align: right" title="Cash">199</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="width: 13%; text-align: right" title="Cash">1,836</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zcdWzFunkV3b" style="text-align: right" title="Accounts receivable">128,392</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Accounts receivable">61,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Accounts receivable">189,732</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other current assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zLVyfzOwAHXa" style="text-align: right" title="Other current assets">89,082</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Other current assets">56,455</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Other current assets">145,536</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property &amp; equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zChmjw1mr94i" style="text-align: right" title="Property &amp; equipment">35,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zrlwIOFN9Iua" style="text-align: right" title="Property &amp; equipment">(2,246</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment_iI_pp0p0_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zO4VgAzTVKrh" style="text-align: right" title="Property &amp; equipment">33,349</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--GoodwillSegement_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zkdU9BLdxez" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill">181,478</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--GoodwillSegement_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_znQKgV09AH1j" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill">(156,563</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--GoodwillSegement_iI_pp0p0_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_z2HHpLHhYSZi" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill">24,770</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsset_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zz5wwjrwK719" style="border-bottom: Black 1pt solid; text-align: right" title="Total assets">436,184</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsset_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zMjv2xZlN349" style="border-bottom: Black 1pt solid; text-align: right" title="Total assets">(40,779</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsset_iI_pp0p0_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_z5SUkoujV0Ue" style="border-bottom: Black 1pt solid; text-align: right" title="Total assets">395,223</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Assumed liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zBes6d4qQB4l" style="text-align: right" title="Assumed liabilities">371,184</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Assumed liabilities">56,755</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="text-align: right" title="Assumed liabilities">314,247</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Gain on acquisition</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pp0p0_di0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zhLZFG8PUpw2" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on acquisition">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pp0p0_di_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zf7UxDxuROea" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on acquisition">(15,976</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_iNI_pp0p0_di_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zbOqdmBRFNIf" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on acquisition">(15,976</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Consideration for 100% of equity interests</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--AmountsRecognizedAsOfAcquisitionDateMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zDqtoLsYjWga" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration for 100% of equity interests">65,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0_d0_c20240911__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--MeasurementPeriodAdjustmentsMember__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_zHlpzQOu9eS7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration for 100% of equity interests">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20240911__us-gaap--BusinessAcquisitionAxis__custom--OptilanIndiaPVTLtdAndOptilanCommunicationAndSecuritySystemsLtdMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration for 100% of equity interests">65,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1637 199 1836 128392 61376 189732 89082 56455 145536 35595 -2246 33349 181478 -156563 24770 436184 -40779 395223 371184 56755 314247 -0 15976 15976 65000 0 65000 <p id="xdx_80F_eus-gaap--RevenueFromContractWithCustomerTextBlock_zXYhopEWlKHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 5 – <span id="xdx_82E_zlCwEuO0lrs8">REVENUE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The following table is a summary of the Company’s timing of revenue recognition for the years ended December 31, 2025 and 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfTimingOfRevenueTableTextBlock_zFDOrrqXLSd2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Timing of revenue recognition)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zE8G22Rr4Aa" style="display: none">Schedule of timing of revenue recognition</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Services and products transferred at a point in time</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_ziNJp2gaGLxe" style="width: 13%; text-align: right" title="Total revenue">57,776</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zuWour9XhC2g" style="width: 13%; text-align: right" title="Total revenue">49,466</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Services and products transferred over time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20250101__20251231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zPwO8IHLLtgi" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">248,716</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_ziHzS0rBAkBh" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">77,370</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231_zL4tHI97vUW7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231_z6RE9jLjdsYa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company disaggregates revenue by source and geographic destination to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Revenue by source consisted of the following for the years ended December 31, 2025 and 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--DisaggregationOfRevenueTableTextBlock_zP3h3J29pL4j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Revenue by source)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BB_zqrMxHEs6pab" style="display: none">Schedule of revenue by source</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>Years Ended</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20250101__20251231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zNdtKaKXLkv1" style="width: 13%; text-align: right" title="Total revenue">0</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zJ1GievfOZL7" style="width: 13%; text-align: right" title="Total revenue">0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Services</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zdaVthLmFpkk" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zJj1kgH7XbL7" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231_zELr4qyRBGyj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231_z88jCWQrGpVc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Revenue by geographic destination consisted of the following for the for the years ended December 31, 2025 and 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--RevenueFromExternalCustomersByGeographicAreasTableTextBlock_zKFjmRI33g06" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Revenue by geographic destination)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zffNzJojRP47" style="display: none">Schedule of revenue by geographic destination</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>Years Ended</b></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_ztdHwnRB7gj8" style="width: 13%; text-align: right" title="Total revenue">41,003</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_z9E8gEc6duye" style="width: 13%; text-align: right" title="Total revenue">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">United Kingdom</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--StatementGeographicalAxis__country--GB_zSzpcTJjjFhe" style="text-align: right" title="Total revenue">126,836</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Rest of world</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zlewkImZCSz" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">267,489</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zGIWDZjVvXK7" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231_znmOkcRtRsMh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231_zXfIKso7AuJ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Contracts</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Contract revenue is recognized over time using the cost-to-cost measure of progress for fixed price contracts. The cost-to-cost measure of progress best depicts the continuous transfer of control of goods or services to the customer. The contractual terms provide that the customer compensates the Company for services rendered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Contract costs include all direct materials, labor and subcontracted costs, as well as indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and the costs of capital equipment. The cost estimation and review process for recognizing revenue over time under the cost-to- cost method is based on the professional knowledge and experience of the Company’s project managers, engineers and financial professionals. Management reviews estimates of total contract transaction price and total project costs on an ongoing basis. Changes in job performance, job conditions and management’s assessment of expected variable consideration are factors that influence estimates of the total contract transaction price, total costs to complete those contracts and profit recognition. Changes in these factors could result in revisions to revenue and costs of revenue in the period in which the revisions are determined on a prospective basis, which could materially affect the Company’s consolidated results of operations for that period. Provisions for losses on uncompleted contracts are recorded in the period in which such losses are determined.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Performance Obligations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Accounting Standards Codification (“ASC”) Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The Company’s contracts often require significant integrated services and, even when delivering multiple distinct services, are generally accounted for as a single performance obligation. Contract amendments and change orders are generally not distinct from the existing contract due to the significant integrated service provided in the context of the contract and are accounted for as a modification of the existing contract and performance obligation. The majority of the Company’s performance obligations are completed within one year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">When more than one contract is entered into with a customer on or close to the same date, the Company evaluates whether those contracts should be combined and accounted for as a single contract as well as whether those contracts should be accounted for as more than one performance obligation. This evaluation requires significant judgment and is based on the facts and circumstances of the various contracts, which could change the amount of revenue and profit recognition in a given period depending upon the outcome of the evaluation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2025, the Company had backlog of approximately $0. During the year ended December 31, 2025, there was approximately $0 in revenue recognized pertaining to any backlog.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Contract Assets and Liabilities</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company bill its customers based on contractual terms, including, milestone billings based on the completion of certain phases of the work. Sometimes, billing occurs after revenue recognition, resulting in unbilled revenue, which is accounted for as a contract asset. Sometimes the Company receives advances payments from our customers before revenue is recognized, resulting in deferred revenue, which is accounted for as a contract liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Contract assets in the consolidated balance sheets represents costs and estimated earnings in excess of billings, which arise when revenue has been recorded but the amount has not been billed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Contract assets and liabilities on December 31, 2025 are $<span id="xdx_904_eus-gaap--ContractWithCustomerLiability_pp0p0_c20251231_zIBHcxnpK758">0</span> upon the deconsolidation related to the Optilan liquidation. The following table is a summary of the Company’s activity of contract liabilities related to contracts with customers.</p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ScheduelOfRollforwardContractWithCustomerLiabilityTableTextBlock_zvoB7jVtOoRh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Rollforward of contract liabilities)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zFeTP4k6gYtk" style="display: none">Schedule of roll forward of contract liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance at December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_c20240101__20241231_zuJbgyZc7Fd3" style="width: 13%; text-align: right" title="Contract liabilities, beginning">0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additions through advance billings to or payments from vendors</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AdditionsThroughAdvanceBillingsToOrPaymentsFromVendors_c20240101__20241231_zHulmnsGpJEc" style="text-align: right" title="Additions through advance billings to or payments from vendors">0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Revenue recognized from current period advance billings to or payments from vendors</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--RevenueRecognizedFromCurrentPeriodAdvanceBillingsToOrPaymentsFromVendors_iN_di_c20240101__20241231_zBJiCrFkcYRf" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from current period advance billings to or payments from vendors">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_c20250101__20251231_zwu8NxHyyuD9" style="text-align: right" title="Contract liabilities, beginning">0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Deconsolidation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DeferredRevenuePeriodDeconsolidation_pp0p0_c20250101__20251231_zK9olmNdsNTf" style="border-bottom: Black 1pt solid; text-align: right" title="Deconsolidation of revenue">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ContractWithCustomerLiabilityCurrent_iE_d0_c20250101__20251231_z5ak8KIto3v6" style="border-bottom: Black 2.5pt double; text-align: right" title="Contract liabilities, ending">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Variable Consideration</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Transaction pricing for the Company’s contracts may include variable consideration, such as unapproved change orders, claims, incentives and liquidated damages. Management estimates variable consideration for a performance obligation utilizing estimation methods that best predict the amount of consideration to which the Company will be entitled. Variable consideration is included in the estimated transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.4pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Management’s estimates of variable consideration and determination of whether to include estimated amounts in transaction price are based on past practices with the customer, specific discussions, correspondence or preliminary negotiations with the customer, legal evaluations and all other relevant information that is reasonably available. The effect of a change in variable consideration on the transaction price of a performance obligation is typically recognized as an adjustment to revenue on a cumulative catch-up basis. To the extent unapproved change orders, claims and liquidated damages reflected in transaction price are not resolved in the Company’s favor, or to the extent incentives reflected in transaction price are not earned, there could be reductions in, or reversals of, previously recognized revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfTimingOfRevenueTableTextBlock_zFDOrrqXLSd2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Timing of revenue recognition)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zE8G22Rr4Aa" style="display: none">Schedule of timing of revenue recognition</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Services and products transferred at a point in time</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_ziNJp2gaGLxe" style="width: 13%; text-align: right" title="Total revenue">57,776</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_zuWour9XhC2g" style="width: 13%; text-align: right" title="Total revenue">49,466</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Services and products transferred over time</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20250101__20251231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_zPwO8IHLLtgi" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">248,716</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_ziHzS0rBAkBh" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">77,370</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231_zL4tHI97vUW7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231_z6RE9jLjdsYa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 57776 49466 248716 77370 308492 126836 <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--DisaggregationOfRevenueTableTextBlock_zP3h3J29pL4j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Revenue by source)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BB_zqrMxHEs6pab" style="display: none">Schedule of revenue by source</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>Years Ended</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Products</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20250101__20251231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zNdtKaKXLkv1" style="width: 13%; text-align: right" title="Total revenue">0</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--ProductOrServiceAxis__us-gaap--ProductMember_zJ1GievfOZL7" style="width: 13%; text-align: right" title="Total revenue">0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Services</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zdaVthLmFpkk" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231__srt--ProductOrServiceAxis__us-gaap--ServiceMember_zJj1kgH7XbL7" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231_zELr4qyRBGyj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231_z88jCWQrGpVc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 0 308492 126836 308492 126836 <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--RevenueFromExternalCustomersByGeographicAreasTableTextBlock_zKFjmRI33g06" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Revenue by geographic destination)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zffNzJojRP47" style="display: none">Schedule of revenue by geographic destination</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>Years Ended</b></td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_ztdHwnRB7gj8" style="width: 13%; text-align: right" title="Total revenue">41,003</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_z9E8gEc6duye" style="width: 13%; text-align: right" title="Total revenue">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">United Kingdom</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--StatementGeographicalAxis__country--GB_zSzpcTJjjFhe" style="text-align: right" title="Total revenue">126,836</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Rest of world</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zlewkImZCSz" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">267,489</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20241231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zGIWDZjVvXK7" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20251231_znmOkcRtRsMh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">308,492</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20241231_zXfIKso7AuJ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">126,836</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 41003 0 126836 267489 0 308492 126836 0 <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ScheduelOfRollforwardContractWithCustomerLiabilityTableTextBlock_zvoB7jVtOoRh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details - Rollforward of contract liabilities)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B4_zFeTP4k6gYtk" style="display: none">Schedule of roll forward of contract liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balance at December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_c20240101__20241231_zuJbgyZc7Fd3" style="width: 13%; text-align: right" title="Contract liabilities, beginning">0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additions through advance billings to or payments from vendors</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--AdditionsThroughAdvanceBillingsToOrPaymentsFromVendors_c20240101__20241231_zHulmnsGpJEc" style="text-align: right" title="Additions through advance billings to or payments from vendors">0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Revenue recognized from current period advance billings to or payments from vendors</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--RevenueRecognizedFromCurrentPeriodAdvanceBillingsToOrPaymentsFromVendors_iN_di_c20240101__20241231_zBJiCrFkcYRf" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from current period advance billings to or payments from vendors">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ContractWithCustomerLiabilityCurrent_iS_c20250101__20251231_zwu8NxHyyuD9" style="text-align: right" title="Contract liabilities, beginning">0</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Deconsolidation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DeferredRevenuePeriodDeconsolidation_pp0p0_c20250101__20251231_zK9olmNdsNTf" style="border-bottom: Black 1pt solid; text-align: right" title="Deconsolidation of revenue">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ContractWithCustomerLiabilityCurrent_iE_d0_c20250101__20251231_z5ak8KIto3v6" style="border-bottom: Black 2.5pt double; text-align: right" title="Contract liabilities, ending">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 0 -0 0 0 0 <p id="xdx_807_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zin5jDlsWfD2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 6 – <span id="xdx_821_z7cXYmY0hlb9">ACCOUNTS RECEIVABLE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Accounts receivable consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zr1h74WdwM0c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BD_zcdOkQra3ve5" style="display: none">Schedule of accounts receivable</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20251231_zSqHOL0Oqpt3" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20241231_zHSHlPDwEGCj" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,050,224</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">920,502</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di0_zvjb6Koli6Fa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(631,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,458</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Accounts receivable, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">419,212</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">915,044</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zr1h74WdwM0c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BD_zcdOkQra3ve5" style="display: none">Schedule of accounts receivable</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20251231_zSqHOL0Oqpt3" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20241231_zHSHlPDwEGCj" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,050,224</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">920,502</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di0_zvjb6Koli6Fa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(631,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,458</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Accounts receivable, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">419,212</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">915,044</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1050224 920502 631012 5458 419212 915044 <p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z1wpQruNdWqb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 7 – <span id="xdx_824_zxoTMJdZnMQd">PROPERTY AND EQUIPMENT, NET</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Property and equipment, net consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJaMyJ9WfoNe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BD_zR4hSOU4rEY8" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Property and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_ztRpMSrhBL0e" style="width: 13%; text-align: right" title="Property and equipment at cost">610,354</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zi5B191jqzH" style="width: 13%; text-align: right" title="Property and equipment at cost">1,125,013</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zP3yE5aiQG9l" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment at cost">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3cvGwq5yhO9" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment at cost">46,934</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt">Property and equipment at cost</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20251231_z5XxMVCZYWu6" style="text-align: right" title="Property and equipment at cost">610,354</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231_z9iC8qNwyAJg" style="text-align: right" title="Property and equipment at cost">1,171,947</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less - accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20251231_zZEcOhsy4cHj" style="border-bottom: Black 1pt solid; text-align: right" title="Less - accumulated depreciation">(63,907</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241231_zuF6kb8T2OKj" style="border-bottom: Black 1pt solid; text-align: right" title="Less - accumulated depreciation">(472,965</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20251231_znOV8tnNJQHe" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">546,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20241231_zMt0NeLswwz4" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">698,982</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Depreciation expenses was $<span id="xdx_90E_eus-gaap--Depreciation_c20250101__20251231_zidKxtbb8nWk">85,198</span> and $<span id="xdx_906_eus-gaap--Depreciation_c20240101__20241231_zPeH7tsTYCu1">128,489</span> for the years ended December 31, 2025 and 2024, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJaMyJ9WfoNe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BD_zR4hSOU4rEY8" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Property and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_ztRpMSrhBL0e" style="width: 13%; text-align: right" title="Property and equipment at cost">610,354</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zi5B191jqzH" style="width: 13%; text-align: right" title="Property and equipment at cost">1,125,013</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zP3yE5aiQG9l" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment at cost">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3cvGwq5yhO9" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment at cost">46,934</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt">Property and equipment at cost</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_pp0p0_c20251231_z5XxMVCZYWu6" style="text-align: right" title="Property and equipment at cost">610,354</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231_z9iC8qNwyAJg" style="text-align: right" title="Property and equipment at cost">1,171,947</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less - accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20251231_zZEcOhsy4cHj" style="border-bottom: Black 1pt solid; text-align: right" title="Less - accumulated depreciation">(63,907</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241231_zuF6kb8T2OKj" style="border-bottom: Black 1pt solid; text-align: right" title="Less - accumulated depreciation">(472,965</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-left: 10pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20251231_znOV8tnNJQHe" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">546,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20241231_zMt0NeLswwz4" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">698,982</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 610354 1125013 0 46934 610354 1171947 63907 472965 546447 698982 85198 128489 <p id="xdx_806_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zqWdGW2qNxj1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 8 - <span id="xdx_829_zwBAn8zKvr47">GOODWILL AND INTANGIBLE ASSETS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Goodwill</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The following is a summary of activity of goodwill for the years ended December 31, 2025 and 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfGoodwillTextBlock_zARDfgSJXBAk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details - Goodwill)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span id="xdx_8BF_z8RZAi6DVkv3" style="display: none">Schedule of goodwill activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; width: 83%; text-align: left">Balances at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iS_pp0p0_d0_c20250101__20251231_zHzzU89Cy8H7" style="width: 13%; text-align: right" title="Goodwill at beginning">23,965</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Acquisition</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--GoodwillImpairmentForAcquisition_pp0p0_d0_c20250101__20251231_zf5YkJFBjyY4" style="text-align: right" title="Acquisition">(23,965</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Foreign exchange translation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--GoodwillForeignCurrencyTranslationGainLoss_pp0p0_d0_c20250101__20251231_zx5IfDD9C2ha" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign exchange translation">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Balances at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Goodwill_iE_pp0p0_d0_c20250101__20251231_zA3mv0SwKqD9" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill at ending">0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zR4YACXWeiG4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Amortization expense was $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20250101__20251231_z5rnOQaNfkUf" title="Amortization expense">0</span> and $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20240101__20241231_zQAk29Z0ufVf" title="Amortization expense">0</span> for the years ended December 31, 2025 and 2024, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Patents - Intrusion Detection Intellectual Property</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company relies on patent laws and restrictions on disclosure to protect its intellectual property rights. As of December 31, 2025 and 2024, the Company held three U.S. and foreign patents on its intrusion detection technology, which expire in calendar years 2027 through 2034 (depending on the payment of maintenance fees).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The DPTI issued patents cover a System and Method for Brillouin Analysis, a System and Method for Resolution Enhancement of a Distributed Sensor, and a Flexible Fiber Optic Deformation System Sensor and Method. Maintenance of intellectual property rights and the protection thereof is important to our business. Any patents that may be issued may not sufficiently protect the Company’s intellectual property and third parties may challenge any issued patents. Other parties may independently develop similar or competing technology or design around any patents that may be issued to the Company. The Company cannot be certain that the steps it has taken will prevent the misappropriation of its intellectual property, particularly in foreign countries where the laws may not protect proprietary rights as fully as in the United States. Further, the Company may be required to enforce its intellectual property or other proprietary rights through litigation, which, regardless of success, could result in substantial costs and diversion of management’s attention. Additionally, there may be existing patents of which the Company is unaware that could be pertinent to its business, and it is not possible to know whether there are patent applications pending that the Company’s products might infringe upon, since these applications are often not publicly available until a patent is issued or published.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">For the years ended December 31, 2025 and 2024, the Company had patent amortization costs on its intrusion detection technology totaling $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zyJ3alc6AhPc" title="Patent amortization costs">51,028</span> and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20240101__20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zZXqwjwhjXLj" title="Patent amortization costs">51,028</span>, respectively. Patents costs are being amortized over the remaining life of each patent, which is from <span id="xdx_902_ecustom--FiniteLivedIntangibleAssetUsefulLife1_c20250101__20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zneH9LD5U3na" title="Patents costs useful life">7 to 16 years</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The DPTI issued patents cover a System and Method for Brillouin Analysis, a System and Method for Resolution Enhancement of a Distributed Sensor, and a Flexible Fiber Optic Deformation System Sensor and Method. Maintenance of intellectual property rights and the protection thereof is important to our business. Any patents that may be issued may not sufficiently protect the Company’s intellectual property and third parties may challenge any issued patents. Other parties may independently develop similar or competing technology or design around any patents that may be issued to the Company. The Company cannot be certain that the steps it has taken will prevent the misappropriation of its intellectual property, particularly in foreign countries where the laws may not protect proprietary rights as fully as in the United States. Further, the Company may be required to enforce its intellectual property or other proprietary rights through litigation, which, regardless of success, could result in substantial costs and diversion of management’s attention. Additionally, there may be existing patents of which the Company is unaware that could be pertinent to its business, and it is not possible to know whether there are patent applications pending that the Company’s products might infringe upon, since these applications are often not publicly available until a patent is issued or published.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The following is a summary of the DPTI patents as of December 31, 2025 and 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zgbs803UxeNi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details - Patents)"> <tr style="vertical-align: bottom; background-color: White"> <td style="display: none; text-align: left">Schedule of patents</td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DPTIPatentsMember_zaRwPDmETXQ9" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DPTIPatentsMember_zJyU7B75pycg" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Patents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">904,269</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">904,269</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_zYLIgv95zxCd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(752,662</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(701,634</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_z1STimXS9sMd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Patents, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">151,607</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">202,635</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zl6j4XK44MQb" style="margin: 0"> </p> <p style="margin: 0">Future expected amortization of patents is as follows:</p> <p style="margin: 0"> </p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">As of December 31</span>,</span></p> <p style="margin: 0"></p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zvG6zSWgayH8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details - Future expected amortization of patent)"> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 83%"><span id="xdx_8B7_zpEOQlkr4162" style="display: none">Schedule of future expected amortization of patents</span></td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_492_20251231__dei--LegalEntityAxis__custom--DPTIMember_ziylHQ14Wlma" style="text-align: center; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_zkcrA1YPRD6k" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,028</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_zHKeVmv5nxs2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,028</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_z4YEoBS7EhO5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">49,551</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><b style="display: none">Total patents</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">151,607</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zCHALRijQOwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfGoodwillTextBlock_zARDfgSJXBAk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details - Goodwill)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span id="xdx_8BF_z8RZAi6DVkv3" style="display: none">Schedule of goodwill activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; width: 83%; text-align: left">Balances at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iS_pp0p0_d0_c20250101__20251231_zHzzU89Cy8H7" style="width: 13%; text-align: right" title="Goodwill at beginning">23,965</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Acquisition</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--GoodwillImpairmentForAcquisition_pp0p0_d0_c20250101__20251231_zf5YkJFBjyY4" style="text-align: right" title="Acquisition">(23,965</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Foreign exchange translation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--GoodwillForeignCurrencyTranslationGainLoss_pp0p0_d0_c20250101__20251231_zx5IfDD9C2ha" style="border-bottom: Black 1pt solid; text-align: right" title="Foreign exchange translation">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Balances at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Goodwill_iE_pp0p0_d0_c20250101__20251231_zA3mv0SwKqD9" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill at ending">0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 23965 -23965 0 0 0 0 51028 51028 7 to 16 years <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zgbs803UxeNi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details - Patents)"> <tr style="vertical-align: bottom; background-color: White"> <td style="display: none; text-align: left">Schedule of patents</td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20251231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DPTIPatentsMember_zaRwPDmETXQ9" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20241231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DPTIPatentsMember_zJyU7B75pycg" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedPatentsGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Patents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">904,269</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">904,269</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_zYLIgv95zxCd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(752,662</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(701,634</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_z1STimXS9sMd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Patents, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">151,607</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">202,635</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 904269 904269 752662 701634 151607 202635 <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zvG6zSWgayH8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details - Future expected amortization of patent)"> <tr style="vertical-align: bottom"> <td style="text-align: left; width: 83%"><span id="xdx_8B7_zpEOQlkr4162" style="display: none">Schedule of future expected amortization of patents</span></td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_492_20251231__dei--LegalEntityAxis__custom--DPTIMember_ziylHQ14Wlma" style="text-align: center; width: 13%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_zkcrA1YPRD6k" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,028</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_zHKeVmv5nxs2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">51,028</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_z4YEoBS7EhO5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">49,551</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><b style="display: none">Total patents</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">151,607</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 51028 51028 49551 151607 <p id="xdx_80E_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_z9JwTfVFq9fc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 9 – <span id="xdx_82F_z3EnswWrdkJk">JOINT VENTURE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On September 9, 2022, the Company entered into a Joint Venture Agreement with Neural Signals Inc, (“NSI”), for the purpose of developing, marketing and selling products and services based on the patents issued to NSI. The parties established the Joint Venture, Neural Logistics Inc., under a separate entity to conduct business. The Company has <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220909__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NeuralSignalsIncMember_z7Sk8Gkha6Rc" title="Ownership percentage">50</span>% ownership in NSI. The Company determined that the investment was accounted for as an equity investment under ASC 323-10-30-2.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the year ended December 31, 2025, the Company contributed $<span id="xdx_906_eus-gaap--PaymentsToAcquireInterestInJointVenture_c20250101__20251231_zkdc4I53kTFg" title="Contributed joint venture">0</span> to the joint venture and recorded a loss on the equity investment of $<span id="xdx_90E_eus-gaap--DebtAndEquitySecuritiesGainLoss_c20250101__20251231_zHqqrEvQrko2" title="Loss on equity investment">0</span>. During the year ended December 31, 2024, the Company contributed $<span id="xdx_900_eus-gaap--PaymentsToAcquireInterestInJointVenture_pp0p0_c20240101__20241231_zUAcZVPmvyX7" title="Contributed joint venture">0</span> to the joint venture and recorded a loss on the equity investment of $<span id="xdx_90B_eus-gaap--DebtAndEquitySecuritiesGainLoss_pp0p0_c20240101__20241231_zjdkSq6qpck1" title="Loss on equity investment">0</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 0.50 0 0 0 0 <p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zWod96xzNVXe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 10 – <span id="xdx_82A_zKxmF3H0zYs2">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Accounts payable and accrued expenses consists of the following as of December 31, 2025 and December 31, 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zVKdxdzv0zP4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BC_z26a1ZBkXvrd" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20251231_zbYrkmqdSTZ6" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20241231_zulxV0nftTD2" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maOAPAAzpXR_zYLpfQ0Ye5Dc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">15,155,264</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">16,863,559</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzpXR_zqsLZ9eIY8Tc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,488,062</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzpXR_z3iI2Mdvi721" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total accounts payable and accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,643,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,863,559</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zVKdxdzv0zP4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BC_z26a1ZBkXvrd" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20251231_zbYrkmqdSTZ6" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20241231_zulxV0nftTD2" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maOAPAAzpXR_zYLpfQ0Ye5Dc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">15,155,264</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">16,863,559</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAzpXR_zqsLZ9eIY8Tc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,488,062</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzpXR_z3iI2Mdvi721" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Total accounts payable and accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18,643,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,863,559</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 15155264 16863559 3488062 0 18643326 16863559 <p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zfDAj084WVN5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 11 – <span id="xdx_823_zYjMNdazZjoj">DEBT</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Convertible Notes</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company uses the Black-Scholes Model to calculate the derivative value of its convertible debt and certain promissory notes. The valuation result generated by this pricing model is necessarily driven by the value of the underlying common stock incorporated into the model. The values of the common stock used were based on the price at the date of issue of the debt security as of December 31, 2025 and 2024. In 2023 management determined the expected volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231_zI2GwsvkpPHi" title="Volatility rate">106.90</span>%, a risk-free rate of interest of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231_zDiGohGNPW8g" title="Risk-free rate of interest">5.48</span>%, and contractual lives of the debt of three months. In 2022 management determined the expected volatility of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231_zeGLSweiGxuh" title="Volatility rate">140.30</span>%, a risk-free rate of interest of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_zhrnCGqfz5Ok" title="Risk-free rate of interest">4.73</span>%, and contractual lives of the debt of three months. Management made the determination to use an expected life rather than contractual life for the calculations for the matured debt as of December 31, 2024 and 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2025 and, 2024, there was $<span id="xdx_90D_eus-gaap--ConvertibleDebt_iI_c20251231_zURoxK33DGMi" title="Convertible debt outstanding">181,000</span> and $<span id="xdx_900_eus-gaap--ConvertibleDebt_iI_c20241231_zyzQssgrGBcl" title="Convertible debt outstanding">0</span> of certain promissory notes principal outstanding (with variable conversion features embedded in the notes on maturity). During the year ended December 31, 2025 and 2024, $<span id="xdx_90E_eus-gaap--AmortizationOfDebtDiscountPremium_c20250101__20251231_zn6G7woldm5d" title="Amortization of debt discount">0</span> and $<span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_c20240101__20241231_zHcdtfjUfZJ2" title="Amortization of debt discount">0</span> of the debt discount was amortized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The summary of promissory notes are:</p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ConvertibleDebtTableTextBlock_zGHO0hpRE0O3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DEBT (Details - Convertible notes)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zNowLfIk22ub" style="display: none">Schedule of convertible notes</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Principal Outstanding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231_zEufnm91dnqi" style="width: 13%; text-align: right" title="Convertible notes, gross">208,150</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231_zo6XxKdkXnFc" style="width: 13%; text-align: right" title="Convertible notes, gross">166,650</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di0_c20251231_zNiMUvz44T7h" style="border-bottom: Black 1pt solid; text-align: right" title="Less: unamortized debt discount">(27,150</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_c20241231_zloFhQODhqIe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: unamortized debt discount">(45,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt"> Promissory notes, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayableCurrent_iI_pp0p0_d0_c20251231_z6q31ezyG6Nb" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes, net">181,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleNotesPayableCurrent_iI_pp0p0_c20241231_zApCAmTnQc8b" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes, net">120,925</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zuV7aGuTMEJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the years ended December 31, 2025 and 2024, change in fair value of the derivative liability was $<span id="xdx_90C_eus-gaap--ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_c20250101__20251231_zDTWhfYUWs59">(258,864)</span> and $<span id="xdx_90C_eus-gaap--ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_c20240101__20241231_zMBiTJOKOJd4">(45,268)</span>, respectively. The following is a summary of the derivative liability:</p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_zsWDPccLcS72" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DEBT (Details - Derivative liabilities)"> <tr style="vertical-align: bottom; background-color: White"> <td style="display: none; text-align: left">Schedule of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Derivative Liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balances at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iNS_di_c20250101__20251231_ziXpM5ZWLwh9" style="width: 13%; text-align: right" title="Derivative liability, beginning balance">(57,235</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loss on issuance of debt</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1_pp0p0_d0_c20250101__20251231_zwZ02l1aXP79" style="text-align: right" title="Loss on issuance of debt">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Issuance of convertible note - 1800 Diagonal Lending</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_d0_c20250101__20251231_zz55PDohQSI5" style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in fair value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_pp0p0_c20250101__20251231_zeSy8WUATmEf" style="text-align: right" title="Change in fair value">(258,864</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">EMA settlement</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_iN_pp0p0_di0_c20250101__20251231_zYDBbqzMitFj" style="border-bottom: Black 1pt solid; text-align: right" title="EMA settlement">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balances at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iNE_pp0p0_di_c20250101__20251231_z7X7bs4OFcig" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, ending balance">(316,099</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AC_zvJS5CkDlKa6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Notes Payable</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On September 5, 2025 the Company entered into a promissory note for a principal of $<span id="xdx_902_eus-gaap--NotesPayable_iI_c20250905__us-gaap--DebtInstrumentAxis__custom--Sept2025NotePayableMember_zH9ukyWwxAqj" title="Notes payable">65,550</span>, which was funded on September 10, 2025. The note bears interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20250905__us-gaap--DebtInstrumentAxis__custom--Sept2025NotePayableMember_zD7TTu2K0NM1" title="Debt interest rate">15</span>% per annum and matures after nine months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On November 24, 2025, the Company entered into a promissory note for a principal of $<span id="xdx_902_eus-gaap--NotesPayable_iI_c20250905__us-gaap--DebtInstrumentAxis__custom--Nov2025NotePayableMember_zBW7qT5A5ss5" title="Notes payable">65,550</span>, which was funded on November 26,2025. The note bears interest at a rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251124__us-gaap--DebtInstrumentAxis__custom--Nov2025NotePayableMember_z7A2Co9ZJg9h" title="Debt interest rate">15</span>% per annum and matures after nine months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.3pt 0pt 5.4pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On December 3, 2025, the Company entered into a promissory note for a principal of $<span id="xdx_90B_eus-gaap--NotesPayable_iI_c20250905__us-gaap--DebtInstrumentAxis__custom--Dec2025NotePayableMember_zSc0LLHCX388" title="Notes payable">77,050</span>, which was funded on December 4,2025. The note bears interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251203__us-gaap--DebtInstrumentAxis__custom--Dec2025NotePayableMember_zITGgnZW3Gqc" title="Debt interest rate">15</span>% per annum and matures after nine months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Loans Payable</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company’s RI and WS subsidiaries have various loans including Small Business Association (“SBA”) Economic Injury Disaster Loan (“EIDL”) loans, lines of credit and other advances. The loans bear interest with varying rates up to 9.25% per annum. The following is a summary of the loans payable at December 31, 2025 and 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_za3kbKa92fA4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DEBT (Details - Loans payable)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B2_ztQWxc1tHS84" style="display: none">Schedule of loans payable</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20251231_zLKZraqQ41u" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20241231_zJAnJROinH02" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2025</b></td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_403_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--RILineOfCreditMember_zdHLXLnH2ou6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">RI - line of credit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">71,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">153,358</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--RIShortTermLoansMember_zzzMQGgT4im9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">RI - Short-term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,402</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,544</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSLineOfCreditMember_zN1HeeoWlEYi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">WS - line of credit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">163,661</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">218,616</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSShortTermLoansMember_zcCdForM0uf7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">WS - Short-term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">151,970</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LoansPayableCurrent_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--OptilanCommunicationSecurityLtdShortTermLoanMember_ztVWOrODQjad" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">OPT – Optilan Communications &amp; Security Ltd</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">857</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,042</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LoansPayableCurrent_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--OptilianIndiaDirectorLoansMember_za7wK6gvI8q2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Optlian India – Director loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,875</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LoansPayableCurrent_iI_zcjkHBJFYaP4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Loans payable, current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">359,805</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">571,530</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_402_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--RISBAEIDLMember_zhFwPuX4tFv" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">RI - SBA EIDL</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">102,597</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">102,597</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--RILongTermLoansMember_z8vBmFAAqXIa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">RI - long-term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,506</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,532</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSSBAEIDLMember_zG7UquIXMf7g" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">WS - SBA EIDL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,307</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,307</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSLongTermLoansMember_zlUpEO06Pwmc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">WS - long-term loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">97,006</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">97,532</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LongTermLoansPayable_iI_znUJhGGblfrc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Loans payable, non-current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">281,416</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">291,967</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_ze6HI6EhOI5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of the Company’s subsidiary debt arrangements are guaranteed by former shareholders of the acquired entity. The Company has not assumed these guarantees and has no legal obligation related to such guarantees<b>.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1.0690 0.0548 1.4030 0.0473 181000 0 0 0 <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ConvertibleDebtTableTextBlock_zGHO0hpRE0O3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DEBT (Details - Convertible notes)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zNowLfIk22ub" style="display: none">Schedule of convertible notes</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Principal Outstanding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231_zEufnm91dnqi" style="width: 13%; text-align: right" title="Convertible notes, gross">208,150</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231_zo6XxKdkXnFc" style="width: 13%; text-align: right" title="Convertible notes, gross">166,650</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di0_c20251231_zNiMUvz44T7h" style="border-bottom: Black 1pt solid; text-align: right" title="Less: unamortized debt discount">(27,150</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_pp0p0_di_c20241231_zloFhQODhqIe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: unamortized debt discount">(45,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt"> Promissory notes, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayableCurrent_iI_pp0p0_d0_c20251231_z6q31ezyG6Nb" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes, net">181,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleNotesPayableCurrent_iI_pp0p0_c20241231_zApCAmTnQc8b" style="border-bottom: Black 2.5pt double; text-align: right" title="Convertible notes, net">120,925</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 208150 166650 27150 45725 181000 120925 -258864 -45268 <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfServicingLiabilitiesAtFairValueTextBlock_zsWDPccLcS72" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DEBT (Details - Derivative liabilities)"> <tr style="vertical-align: bottom; background-color: White"> <td style="display: none; text-align: left">Schedule of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Derivative Liability</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Balances at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iNS_di_c20250101__20251231_ziXpM5ZWLwh9" style="width: 13%; text-align: right" title="Derivative liability, beginning balance">(57,235</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loss on issuance of debt</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1_pp0p0_d0_c20250101__20251231_zwZ02l1aXP79" style="text-align: right" title="Loss on issuance of debt">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Issuance of convertible note - 1800 Diagonal Lending</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_d0_c20250101__20251231_zz55PDohQSI5" style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Change in fair value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_pp0p0_c20250101__20251231_zeSy8WUATmEf" style="text-align: right" title="Change in fair value">(258,864</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">EMA settlement</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_iN_pp0p0_di0_c20250101__20251231_zYDBbqzMitFj" style="border-bottom: Black 1pt solid; text-align: right" title="EMA settlement">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balances at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_iNE_pp0p0_di_c20250101__20251231_z7X7bs4OFcig" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, ending balance">(316,099</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 57235 0 0 -258864 -0 316099 65550 0.15 65550 0.15 77050 0.15 <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_za3kbKa92fA4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - DEBT (Details - Loans payable)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B2_ztQWxc1tHS84" style="display: none">Schedule of loans payable</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20251231_zLKZraqQ41u" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20241231_zJAnJROinH02" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2025</b></td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_403_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--RILineOfCreditMember_zdHLXLnH2ou6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">RI - line of credit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">71,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">153,358</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--RIShortTermLoansMember_zzzMQGgT4im9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">RI - Short-term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,402</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,544</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSLineOfCreditMember_zN1HeeoWlEYi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">WS - line of credit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">163,661</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">218,616</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LoansPayableCurrent_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSShortTermLoansMember_zcCdForM0uf7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">WS - Short-term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">151,970</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LoansPayableCurrent_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--OptilanCommunicationSecurityLtdShortTermLoanMember_ztVWOrODQjad" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">OPT – Optilan Communications &amp; Security Ltd</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">857</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,042</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LoansPayableCurrent_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--OptilianIndiaDirectorLoansMember_za7wK6gvI8q2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Optlian India – Director loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,875</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LoansPayableCurrent_iI_zcjkHBJFYaP4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Loans payable, current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">359,805</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">571,530</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_402_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--RISBAEIDLMember_zhFwPuX4tFv" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">RI - SBA EIDL</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">102,597</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">102,597</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--RILongTermLoansMember_z8vBmFAAqXIa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">RI - long-term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,506</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,532</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSSBAEIDLMember_zG7UquIXMf7g" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">WS - SBA EIDL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,307</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,307</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LongTermLoansPayable_iI_hus-gaap--LongtermDebtTypeAxis__custom--WSLongTermLoansMember_zlUpEO06Pwmc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">WS - long-term loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">97,006</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">97,532</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LongTermLoansPayable_iI_znUJhGGblfrc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Loans payable, non-current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">281,416</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">291,967</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 71285 153358 32402 46544 163661 218616 91600 151970 857 1042 3875 0 359805 571530 102597 102597 55506 63532 26307 26307 97006 97532 281416 291967 <p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zOYmrm8eqSMf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 12 – <span id="xdx_82C_zN5VhT8y95Si">SECURED DEBENTURE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">DPTI issued a convertible Debenture to the University (see Note 1) in exchange for the Patents assigned to the Company, in the amount of Canadian $1,500,000, or US $1,491,923 on December 16, 2010, the date of the Debenture. On April 24, 2017 DPTI issued a replacement secured term Debenture in the same CAD 1,500,000 amount as the original Debenture. The interest rate is the Bank of Canada Prime overnight rate plus 1% per annum. The Debenture had an initial required payment of CAD 42,000 (US$33,385) due on April 24, 2018 for reimbursement to the University of its research and development costs, and this has been paid. Interest-only maintenance payments are due annually starting after April 24, 2018. Payment of the principal begins on the earlier of (a) three years following two consecutive quarters of positive earnings before interest, taxes, depreciation and amortization, (b) six years from April 24, 2017, or (c) in the event DPTI fails to raise defined capital amounts or secure defined contract amounts by April 24 in the years 2018, 2019, and 2020. The Company has raised funds in excess of the amount required for 2020, 2019 and 2018. Beginning in 2023, The principal repayment amounts will be due quarterly over a six-year period in the amount of Canadian Dollars 62,500. Based on the exchange rate between the Canadian Dollar and the U.S. Dollar on December 31, 2018, the quarterly principal repayment amounts will be US$48,447. The Debenture is secured by the Patents assigned by the University to DPTI by an Assignment Agreement on December 16, 2010. DPTI has pledged the Patents, and granted a lien on them pursuant to an Escrow Agreement dated April 24, 2017, between DPTI and the University.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Debenture was initially recorded at the $1,491,923 equivalent US Dollar amount of Canadian 1,500,000 as of December 16, 2010, the date of the original Debenture. The liability is being adjusted quarterly based on the current exchange value of the Canadian dollar to the US dollar at the end of each quarter. The adjustment is recorded as unrealized gain or loss in the change of the value of the two currencies during the quarter. The Debenture also includes a provision requiring DPTI to pay the University a 2% royalty on sales of any and all products or services which incorporate the Patents for a period of five years from April 24, 2018. To date, no royalties have been paid.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">For the years ended December 31, 2025 and 2024, the Company recorded interest expense of $<span id="xdx_90B_eus-gaap--InterestAndDebtExpense_c20250101__20251231_z8YiPn6q5CGe" title="Interest expense">21,116</span> and $<span id="xdx_909_eus-gaap--InterestAndDebtExpense_c20240101__20241231_ztDg4ZkWdXQa" title="Interest expense">66,813</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2025, and December 31, 2024, the outstanding balance of the debenture liability totaled $<span id="xdx_903_eus-gaap--LongTermDebt_iI_c20251231_zPlAfWvNKiEa" title="Debenture liability">614,756</span> and $<span id="xdx_905_eus-gaap--LongTermDebt_iI_c20241231_zOtAVvmTqnGb" title="Debenture liability">1,041,664</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Future minimum required payments over the next five years and thereafter are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Period ending December 31</span>,</span></p> <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zEh6ntfNqZbc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SECURED DEBENTURE (Details - Future minimum required payments)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zpO6fJo6SsF" style="display: none">Schedule of future minimum required payments</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20251231_z7HYS8hNU5H7" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">273,225</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">273,225</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; text-align: left">2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68,306</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><b style="display: none">Total</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">614,756</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> 21116 66813 614756 1041664 <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zEh6ntfNqZbc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SECURED DEBENTURE (Details - Future minimum required payments)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zpO6fJo6SsF" style="display: none">Schedule of future minimum required payments</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20251231_z7HYS8hNU5H7" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: left">2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">273,225</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">273,225</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; text-align: left">2025</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">68,306</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><b style="display: none">Total</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">614,756</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 273225 273225 68306 614756 <p id="xdx_80B_eus-gaap--LesseeOperatingLeasesTextBlock_zXOTiO6WM4ia" style="margin: 0"><b>NOTE 13 – <span id="xdx_82F_zErBU6NT6y9e">LEASES</span></b></p> <p style="margin: 0"> </p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following was included in our balance sheet as of December 31, 2025 and 2024:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--LeaseCostTableTextBlock_zSudXO05xwC1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Balance sheet)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B7_zBfRB5S5klxg" style="display: none">Schedule of operating lease</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20251231_zWSuCyjJyFJ1" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20241231_zEOsHD1LQMu" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold"><span style="text-decoration: underline">Operating leases</span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-style: italic">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_d0_zRrHTpjRToXf" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left">ROU operating lease assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">449,556</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_d0_zuhcgA6yGJG6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Current portion of operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">80,400</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_d0_zqEsOLD2rEO6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease, net of current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">447,009</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeaseLiability_iI_pp0p0_d0_zlpJWYVVhHPg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">527,409</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z0lrERsgX4a5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The weighted average remaining lease term and weighted average discount rate at December 31, 2025 and 2024 were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateTableTextBlock_zRjJgG3r0lyf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Other information)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BB_zkaCbL3LQrbc" style="display: none">Schedule of weighted average remaining lease term and discount rate</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold"><span style="text-decoration: underline">Operating leases</span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Weighted average remaining lease term (years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20251231_zketzNJecrc" title="Weighted average remaining lease term (years)">7.75</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zkBHgol9cegk" title="Weighted average remaining lease term (years)">7.25</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Weighted average discount rate</p></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20251231_zQP3AUjCPyLg" title="Weighted average discount rate">6.00</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20241231_zeslsUwBcpfk" title="Weighted average discount rate">6.00</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A8_zdemeZqcLF94" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Operating Leases</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On June 28, 2023, the Company recognized a gain on deconsolidation of $1,642,146 related to Optilan (UK) and its subsidiaries leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--LeaseCostTableTextBlock_zSudXO05xwC1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Balance sheet)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B7_zBfRB5S5klxg" style="display: none">Schedule of operating lease</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20251231_zWSuCyjJyFJ1" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20241231_zEOsHD1LQMu" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold"><span style="text-decoration: underline">Operating leases</span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-style: italic">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_d0_zRrHTpjRToXf" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left">ROU operating lease assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">449,556</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_d0_zuhcgA6yGJG6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Current portion of operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">80,400</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_d0_zqEsOLD2rEO6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Operating lease, net of current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">447,009</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeaseLiability_iI_pp0p0_d0_zlpJWYVVhHPg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">527,409</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 449556 0 80400 0 447009 0 527409 <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermAndWeightedAverageDiscountRateTableTextBlock_zRjJgG3r0lyf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Other information)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BB_zkaCbL3LQrbc" style="display: none">Schedule of weighted average remaining lease term and discount rate</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold"><span style="text-decoration: underline">Operating leases</span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Weighted average remaining lease term (years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20251231_zketzNJecrc" title="Weighted average remaining lease term (years)">7.75</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20241231_zkBHgol9cegk" title="Weighted average remaining lease term (years)">7.25</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Weighted average discount rate</p></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20251231_zQP3AUjCPyLg" title="Weighted average discount rate">6.00</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20241231_zeslsUwBcpfk" title="Weighted average discount rate">6.00</span></td><td style="text-align: left">%</td></tr> </table> P7Y9M P7Y3M 0.0600 0.0600 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z6rYGs9EUQg6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 14 – <span id="xdx_821_zqUhIE1d83jl">STOCKHOLDERS’ EQUITY (DEFICIT)</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Preferred Stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In accordance with the Company’s bylaws, the Company has authorized a total of <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zah3204elA" title="Preferred stock, shares authorized"><span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zqaa8L3Z8DS3" title="Preferred stock, shares authorized">2,000,000</span></span> shares of preferred stock, par value $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zASIQQEDDTg6" title="Preferred stock, par value"><span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_znTqpFYhLzBe" title="Preferred stock, par value">0.01</span></span> per share, for all classes. As of December 31, 2025 and 2024 respectively, there were <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zMfMIuInhoD9" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zEuLXSQNTbse" title="Preferred stock, shares outstanding">88,335</span></span> and <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zP5xtocdjDP1" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z9cv9vpxJj5" title="Preferred stock, shares outstanding">88,335</span></span> total preferred shares issued and outstanding for all classes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Common Stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In accordance with the Company’s bylaws, the Company has authorized a total of <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20251231_zhdZi30uctoh" title="Common stock, shares authorized"><span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20241231_z1R5Tq3hfZF3" title="Common stock, shares authorized">20,000,000,000</span></span> shares of common stock, par value $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20251231_zHeht6oWWgL4" title="Common stock par value"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241231_zYuXC1T1dF1a" title="Common stock par value">0.0001</span></span> per share. As of December 31, 2025 and 2024, there were <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRaApEnhtCpd" title="Common stock, shares issued">90,904,606</span> and <span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlh8OIAVP1H7" title="Common stock, shares issued">40,500,587</span> common shares issued, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The below table of puts from 1/12/2023 through 4/11/2023 were made by the Company under the 2022 EFA during 2023. The put from 4/28/2023 was made under the EFA dated 4/28/2023. The puts from 6/26/2023 and 7/3/2023 were made by the Company under the Amended EFA dated June 13, 2023. The 7/10/2023 put was made by the Company under the Second Amended EFA dated July 10, 2023.</p> <table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfEquityFinancingAgreementEFATableTextBlock_zO7qJdKOyFYa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details - Equity financing EFA)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span id="xdx_8B5_zg7y4pBcJVxh" style="display: none">Schedule of equity financing agreement</span></td><td> </td> <td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Date of Put</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Number of Common <br/>Shares Issued</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total Proceeds,</p> <p style="margin-top: 0; margin-bottom: 0">Net of Discounts</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Effective Price <br/>per Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net Proceeds</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 33%; text-align: center; padding-left: 0.05pt">1/12/2023</td><td style="width: 2%"> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230110__20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFPz8DiG6vt" style="width: 13%; text-align: right" title="Number of common shares issued">64,130,435</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230110__20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zuXNDXuUhhW5" style="width: 13%; text-align: right" title="Total proceeds, net of discounts">400,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockPricePerShare_iI_c20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zK57JBm5LHnh" style="width: 13%; text-align: right" title="Effective price per share">0.006237</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230110__20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z8i3EPzV2PAg" style="width: 13%; text-align: right" title="Net proceeds, net of discounts">370,975</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">1/17/2023*</td><td> </td> <td id="xdx_98B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230116__20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlEXfwgwHJ92" style="text-align: right" title="Number of common shares issued">11,441,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230116__20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zajixsy7Jm1j" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SaleOfStockPricePerShare_iI_c20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhqr28vHqKg9" style="text-align: right" title="Effective price per share">0.008740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230116__20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zQSrQlBy0MDb" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">1/24/2023</td><td> </td> <td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230123__20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zOzKnMLSsALb" style="text-align: right" title="Number of common shares issued">77,733,861</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230123__20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z5uraPZcPUJ8" style="text-align: right" title="Total proceeds, net of discounts">400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SaleOfStockPricePerShare_iI_c20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeYdtHmad8Zf" style="text-align: right" title="Effective price per share">0.005146</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230123__20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zqU1EqybtMMa" style="text-align: right" title="Total proceeds, net of discounts">370,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2/3/2023</td><td> </td> <td id="xdx_986_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230202__20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfk2mnNZymE6" style="text-align: right" title="Number of common shares issued">61,173,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230202__20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zEAfVW8elTAd" style="text-align: right" title="Total proceeds, net of discounts">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SaleOfStockPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zneCGlmJWNV3" style="text-align: right" title="Effective price per share">0.004904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230202__20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKTsRjzq3yGd" style="text-align: right" title="Total proceeds, net of discounts">277,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">2/17/2023</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230216__20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_znTBpjF5kXA4" style="text-align: right" title="Number of common shares issued">75,447,571</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230216__20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zUr8Gz8C03ia" style="text-align: right" title="Total proceeds, net of discounts">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockPricePerShare_iI_c20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zUpk9dUrOkGi" style="text-align: right" title="Effective price per share">0.003976</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230216__20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zdPYnyKDTjO9" style="text-align: right" title="Total proceeds, net of discounts">277,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">3/1/2023</td><td> </td> <td id="xdx_98E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230228__20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zH4RrVOFiSi3" style="text-align: right" title="Number of common shares issued">83,113,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230228__20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKxWAXEg4Io2" style="text-align: right" title="Total proceeds, net of discounts">324,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SaleOfStockPricePerShare_iI_c20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zCbK94FDbx73" style="text-align: right" title="Effective price per share">0.003898</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230228__20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zk2mZsKFasqg" style="text-align: right" title="Total proceeds, net of discounts">300,295</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">3/16/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230315__20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zi4U8RAjON0f" style="text-align: right" title="Number of common shares issued">93,165,852</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230315__20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zoVaCd3QVbof" style="text-align: right" title="Total proceeds, net of discounts">254,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SaleOfStockPricePerShare_iI_c20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z56ssiDEFL6g" style="text-align: right" title="Effective price per share">0.002729</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230315__20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zC3CM28eAvY3" style="text-align: right" title="Total proceeds, net of discounts">235,410</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">3/30/2023</td><td> </td> <td id="xdx_98A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230329__20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zwkBZYakr7nk" style="text-align: right" title="Number of common shares issued">65,465,384</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230329__20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zxFXV7JQyxpc" style="text-align: right" title="Total proceeds, net of discounts">166,903</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SaleOfStockPricePerShare_iI_c20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfpRwTi5egZb" style="text-align: right" title="Effective price per share">0.002549</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230329__20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zHRvQqOYjUf5" style="text-align: right" title="Total proceeds, net of discounts">154,195</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-left: 0.05pt">4/11/2023</td><td> </td> <td id="xdx_980_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230410__20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIUy8CLw8AJj" style="text-align: right" title="Number of common shares issued">67,462,162</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230410__20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIlXd65iTq3i" style="text-align: right" title="Total proceeds, net of discounts">203,554</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SaleOfStockPricePerShare_iI_c20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZyBLM54dU6j" style="text-align: right" title="Effective price per share">0.003017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230410__20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zHCHWM6Wi3k5" style="text-align: right" title="Total proceeds, net of discounts">188,279</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">4/28/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230427__20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zWpdUz7yvpoc" style="text-align: right" title="Number of common shares issued">91,796,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230427__20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z0ySGHLtxK6c" style="text-align: right" title="Total proceeds, net of discounts">235,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockPricePerShare_iI_c20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zATdUyzSyIzi" style="text-align: right" title="Effective price per share">0.002560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230427__20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYzvd4Fy2NWl" style="text-align: right" title="Total proceeds, net of discounts">208,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">6/26/2023</td><td> </td> <td id="xdx_98F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230625__20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zuRYp0WbP8pl" style="text-align: right" title="Number of common shares issued">44,583,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230625__20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zjBeUklViJi2" style="text-align: right" title="Total proceeds, net of discounts">214,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SaleOfStockPricePerShare_iI_c20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z0uVTb4p7Myk" style="text-align: right" title="Effective price per share">0.004800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230625__20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zulgJPcuUVR6" style="text-align: right" title="Total proceeds, net of discounts">141,020</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">7/3/2023</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230702__20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFg8bNeG5Bud" style="text-align: right" title="Number of common shares issued">51,442,308</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230702__20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKXrMfIeNjT5" style="text-align: right" title="Total proceeds, net of discounts">274,058</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SaleOfStockPricePerShare_iI_c20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcWhvI6K9gZi" style="text-align: right" title="Effective price per share">0.004200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230702__20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zH4YZW4LenZ" style="text-align: right" title="Total proceeds, net of discounts">257,020</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">7/10/2023</td><td> </td> <td id="xdx_98F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230709__20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zXjwVHyZQLDh" style="text-align: right" title="Number of common shares issued">28,593,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230709__20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYP4VrLsvVu9" style="text-align: right" title="Total proceeds, net of discounts">91,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockPricePerShare_iI_c20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zmWf7xDfhfZ1" style="text-align: right" title="Effective price per share">0.003200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230709__20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zC9E8jmtRCZ7" style="text-align: right" title="Total proceeds, net of discounts">85,094</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">9/5/2023*</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230904__20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z7OUPGpDihlb" style="text-align: right" title="Number of common shares issued">100,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230904__20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zG0yeehl3RRb" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SaleOfStockPricePerShare_iI_c20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zvR47EsQERMj" style="text-align: right" title="Effective price per share">0.001000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230904__20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbAYymXbkt4l" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">11/7/2023*</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231106__20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zrCUdloqDgMg" style="text-align: right" title="Number of common shares issued">55,555,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231106__20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zAAaWNAVAVXf" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SaleOfStockPricePerShare_iI_c20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbiY9Csxtkel" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231106__20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYy49KkTCAph" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">11/8/2023*</td><td> </td> <td id="xdx_981_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231105__20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zEh8zZVJ6R3" style="text-align: right" title="Number of common shares issued">33,333,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231105__20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZwmXDfhfjBi" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SaleOfStockPricePerShare_iI_c20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zm1kHSy7Pqzg" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231105__20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zepbu0SKnTu5" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">11/14/2023</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231113__20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlaD8sUybyLl" style="text-align: right" title="Number of common shares issued">18,997,442</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231113__20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zt7sbbBZO1Ad" style="text-align: right" title="Total proceeds, net of discounts">25,180</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockPricePerShare_iI_c20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z7Rrw2EvIx16" style="text-align: right" title="Effective price per share">0.001325</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231113__20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbM6kuY4aGCh" style="text-align: right" title="Total proceeds, net of discounts">22,392</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">11/22/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231121__20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zp1VPpTfIz9b" style="text-align: right" title="Number of common shares issued">29,685,620</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231121__20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSapoKfgqXgk" style="text-align: right" title="Total proceeds, net of discounts">34,717</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SaleOfStockPricePerShare_iI_c20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziHtpjINOsx" style="text-align: right" title="Effective price per share">0.001169</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231121__20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhLRRR40KLFj" style="text-align: right" title="Total proceeds, net of discounts">31,262</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-left: 0.1pt">11/29/2023*</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231128__20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zj6w6206iPM6" style="text-align: right" title="Number of common shares issued">55,555,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231128__20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zMsz01wzHjQk" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockPricePerShare_iI_c20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFEbDC3OdR87" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231128__20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zh00yVH0vmS7" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0.1pt">11/30/2023*</td><td> </td> <td id="xdx_98D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231127__20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z7Z7pF0Y9LVk" style="text-align: right" title="Number of common shares issued">27,777,777</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231127__20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_znfKMXSWIhK1" style="text-align: right" title="Total proceeds, net of discounts">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zddudheSVCvj" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231127__20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zVfgudvRcnR9" style="text-align: right" title="Total proceeds, net of discounts">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">12/1/2023*</td><td> </td> <td id="xdx_98C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfVjH04yFsH5" style="text-align: right" title="Number of common shares issued">33,333,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTMHP3kYTW1i" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SaleOfStockPricePerShare_iI_c20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zoW78qh1lZ3a" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zuNhNJ6VGG8l" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">12/1/2023</td><td> </td> <td id="xdx_987_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_z18fipgEoP26" style="text-align: right" title="Number of common shares issued">51,275,586</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_zCCgVLd2nFHf" style="text-align: right" title="Total proceeds, net of discounts">47,973</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SaleOfStockPricePerShare_iI_c20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_zBnwuq0A8NLk" style="text-align: right" title="Effective price per share">0.000936</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_zZUkZC5hpDvj" style="text-align: right" title="Total proceeds, net of discounts">43,590</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-left: 0.05pt">12/11/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231210__20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZ3A6Gyns0sg" style="text-align: right" title="Number of common shares issued">87,136,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231210__20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zl2ZUXedX2B2" style="text-align: right" title="Total proceeds, net of discounts">108,019</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockPricePerShare_iI_c20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYljVjphPhP4" style="text-align: right" title="Effective price per share">0.001240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231210__20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zX0i6zm0Fa8e" style="text-align: right" title="Total proceeds, net of discounts">99,433</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">12/27/2023</td><td> </td> <td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231226__20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zU39qT0RPLz5" style="text-align: right" title="Number of common shares issued">67,522,014</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231226__20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zF0c7vXUp3c" style="text-align: right" title="Total proceeds, net of discounts">57,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SaleOfStockPricePerShare_iI_c20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaF75dPzhfdf" style="text-align: right" title="Effective price per share">0.000858</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231226__20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zgeDH4Vb2tEd" style="text-align: right" title="Total proceeds, net of discounts">52,830</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">1/8/2024</td><td> </td> <td id="xdx_98E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240107__20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2xO9OPafu4a" style="text-align: right" title="Number of common shares issued">52,162,997</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20240107__20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziEiusNH2Zb9" style="text-align: right" title="Total proceeds, net of discounts">44,736</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockPricePerShare_iI_c20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zn0HykICGhjk" style="text-align: right" title="Effective price per share">.000858</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20240107__20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zH9mXe9A9a59" style="text-align: right" title="Total proceeds, net of discounts">40,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2/29/2024</td><td> </td> <td id="xdx_983_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240228__20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziXpaE1AUZC8" style="text-align: right" title="Number of common shares issued">178,571,428</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20240228__20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zWFJeKRwp0e8" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zVL3yuj2ucv1" style="text-align: right" title="Effective price per share">.000560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20240228__20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDDOlmXv06D4" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">8/19/2024</td><td style="padding-bottom: 1pt"> </td> <td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240818__20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbad6Ws47iCi" style="border-bottom: Black 1pt solid; text-align: right" title="Number of common shares issued">55,555,556</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20240818__20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z1CwCNLK3ZTi" style="border-bottom: Black 1pt solid; text-align: right" title="Total proceeds, net of discounts">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--SaleOfStockPricePerShare_iI_c20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z5yUJux9WK3i" style="padding-bottom: 1pt; text-align: right" title="Effective price per share">.0007200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20240818__20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJJaMfgnCaok" style="border-bottom: Black 1pt solid; text-align: right" title="Total proceeds, net of discounts">36,175</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt"> </td> <td id="xdx_98C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20241231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zBTNhg4wn2fg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of common shares issued">1,662,012,341</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230101__20241231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zNlUxBAF8Q1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">4,006,781</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230101__20241231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJewcCCPMGei" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">3,679,025</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>2024 Transactions</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On November 6, 2024 the Company entered into an Amendment to the 2023 Equity Financing Agreement with GHS, to which GHS agreed to Purchase $<span id="xdx_906_eus-gaap--PaymentsForRepurchaseOfCommonStock_c20241105__20241106__us-gaap--TransactionTypeAxis__custom--EquityFinancingAgreementMember_zHqpJHV2UB6d" title="Purchase of common stock">30,000,000</span> in shares of our Common Stock over the course of 12 months at <span id="xdx_900_ecustom--MarketPricePercentage_dp_c20241105__20241106__us-gaap--TransactionTypeAxis__custom--EquityFinancingAgreementMember_z6eoSqBioExc" title="Market price percentage">92</span>% of the current market price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The RRA provides that we shall (i) use our best efforts to file with the SEC a Registration Statement within 45 days of the date of the GHS Registration Rights Agreement; and (ii) have the Registration Statement declared effective by the SEC within 30 days after the date the GHS Registration Statement is filed with the SEC, but in no event more than 90 days after the GHS Registration Statement is filed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The below table of puts from 1/6/2025 through 12/18/2025 were made by the Company under the EFA amended in November 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details - Equity financing EFA)"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Date of Put</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Common <br/> Shares Issued</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total Proceeds,</p> <p style="margin-top: 0; margin-bottom: 0">Net of Discounts</p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Effective Price <br/> per Share</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net Proceeds</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 33%; text-align: center"><span style="font-size: 10pt">1/6/2025</span></td><td style="width: 2%"> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250105__20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z1n74Z4vPzB7" style="width: 13%; text-align: right" title="Number of common shares issued">183,202</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250105__20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSN2LA7A7Vc7" style="width: 13%; text-align: right" title="Total proceeds, net of discounts">23,450</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zvT8PblXk9V4" style="width: 13%; text-align: right" title="Effective price per share">0.000640</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250105__20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zd1VhRevJZh6" style="width: 13%; text-align: right" title="Net proceeds, net of discounts">20,783</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">1/14/2025</span></td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250113__20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zz4AGp0ujkR2" style="text-align: right" title="Number of common shares issued">256,077</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250113__20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zllBVaXdNv4d" style="text-align: right" title="Total proceeds, net of discounts">32,778</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SaleOfStockPricePerShare_iI_c20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlucLJpbZBD9" style="text-align: right" title="Effective price per share">0.000640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250113__20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zMccK13I3Cn1" style="text-align: right" title="Net proceeds, net of discounts">29,458</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">1/24/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250123__20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFU4aIBB1Otk" style="text-align: right" title="Number of common shares issued">395,308</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250123__20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zadRVEtid6C7" style="text-align: right" title="Total proceeds, net of discounts">50,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockPricePerShare_iI_c20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeW9KS6xgxn2" style="text-align: right" title="Effective price per share">0.000640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250123__20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSoK5jYcoEbg" style="text-align: right" title="Net proceeds, net of discounts">46,050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">1/30/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250129__20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z4TDPbgpGAbe" style="text-align: right" title="Number of common shares issued">695,043</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250129__20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zM5omxAp6t9j" style="text-align: right" title="Total proceeds, net of discounts">55,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zUobzYxgPW3a" style="text-align: right" title="Effective price per share">0.000400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250129__20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zVT74VaRf2fl" style="text-align: right" title="Net proceeds, net of discounts">50,686</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">2/7/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250206__20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zEMI3qzzb9u1" style="text-align: right" title="Number of common shares issued">622,323</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250206__20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zqWVhwCSxGm" style="text-align: right" title="Total proceeds, net of discounts">49,786</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJkIzZVH7KX9" style="text-align: right" title="Effective price per share">0.000399</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250206__20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfhaVv5e5uX6" style="text-align: right" title="Net proceeds, net of discounts">45,276</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">2/18/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250217__20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIyDGowsO4ql" style="text-align: right" title="Number of common shares issued">657,228</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250217__20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z68Yb00psc7e" style="text-align: right" title="Total proceeds, net of discounts">42,063</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcxBXT9QJn52" style="text-align: right" title="Effective price per share">0.000320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250217__20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDeKVNIZACK8" style="text-align: right" title="Net proceeds, net of discounts">38,093</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">2/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250227__20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlZDbD57VO89" style="text-align: right" title="Number of common shares issued">710,373</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250227__20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zb7Zr6MnzLLj" style="text-align: right" title="Total proceeds, net of discounts">34,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z5JNqrXZYJDf" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250227__20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zE88TXJW3yUd" style="text-align: right" title="Net proceeds, net of discounts">30,686</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">3/10/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250309__20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhauAFloRkh7" style="text-align: right" title="Number of common shares issued">663,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250309__20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zT4JeKtaHZJ7" style="text-align: right" title="Total proceeds, net of discounts">31,848</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIDAC8y5jPPh" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250309__20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z3xRTRMdiIO4" style="text-align: right" title="Net proceeds, net of discounts">25,594</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">3/18/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250317__20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zCNAW9G1zgce" style="text-align: right" title="Number of common shares issued">1,122,820</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250317__20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zv1CsGHLRmtk" style="text-align: right" title="Total proceeds, net of discounts">53,895</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzsRI6NnEHFh" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250317__20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfuffRo0rZ94" style="text-align: right" title="Net proceeds, net of discounts">40,098</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">3/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250327__20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zBUgv0gaDcyh" style="text-align: right" title="Number of common shares issued">1,019,222</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250327__20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcR8Y7uMYOJk" style="text-align: right" title="Total proceeds, net of discounts">65,230</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlxdpKboR5k4" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250327__20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzzVrvUlY7eh" style="text-align: right" title="Net proceeds, net of discounts">59,364</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">4/4/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250403__20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziq6dmlsiDG1" style="text-align: right" title="Number of common shares issued">653,076</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250403__20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zA2tfP5rnWdd" style="text-align: right" title="Total proceeds, net of discounts">41,797</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ztS4dD6nkyE2" style="text-align: right" title="Effective price per share">0.000320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250403__20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhW4MWFOQvh9" style="text-align: right" title="Net proceeds, net of discounts">37,846</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">4/14/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250413__20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z9Ge119ZX5Vi" style="text-align: right" title="Number of common shares issued">895,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250413__20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zBOIi4nVjHeh" style="text-align: right" title="Total proceeds, net of discounts">42,963</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zI3fj6iJK6ii" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250413__20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcLnPZzDzTv4" style="text-align: right" title="Net proceeds, net of discounts">38,931</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">4/23/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250422__20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zc4XGjdvpoyh" style="text-align: right" title="Number of common shares issued">906,671</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250422__20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zirCOshGxgEj" style="text-align: right" title="Total proceeds, net of discounts">58,027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zmYUAdt4rN89" style="text-align: right" title="Effective price per share">0.000320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250422__20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z6BD69szCEZb" style="text-align: right" title="Net proceeds, net of discounts">52,940</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">5/1/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250430__20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzkzz5KYDBj6" style="text-align: right" title="Number of common shares issued">1,126,922</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250430__20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlcfCWfJBEAi" style="text-align: right" title="Total proceeds, net of discounts">46,844</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTSFTOLB3d9i" style="text-align: right" title="Effective price per share">0.000249</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250430__20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zd5aiBJitg95" style="text-align: right" title="Net proceeds, net of discounts">42,540</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">5/9/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250508__20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSM9QolWLT04" style="text-align: right" title="Number of common shares issued">941,402</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250508__20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFS9T6HjoSJd" style="text-align: right" title="Total proceeds, net of discounts">43,273</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zOumhNprlaZj" style="text-align: right" title="Effective price per share">0.000190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250508__20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zHc5KbDVKQ7h" style="text-align: right" title="Net proceeds, net of discounts">39,219</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">5/21/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250520__20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeHw1XWmwI4f" style="text-align: right" title="Number of common shares issued">949,987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250520__20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zXH2z14TyDrc" style="text-align: right" title="Total proceeds, net of discounts">30,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z9HaNVeDTQ9a" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250520__20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2iJMt9ciVNl" style="text-align: right" title="Net proceeds, net of discounts">27,247</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">5/30/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250529__20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zjMps2n2YHJ8" style="text-align: right" title="Number of common shares issued">1,127,583</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250529__20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcDbZFUlcLch" style="text-align: right" title="Total proceeds, net of discounts">36,083</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTxcI59vZcNe" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250529__20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zNnrf6yXzPx1" style="text-align: right" title="Net proceeds, net of discounts">32,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">6/10/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250609__20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIyCkxLNhlR7" style="text-align: right" title="Number of common shares issued">1,130,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250609__20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zz2dlXNcqWtc" style="text-align: right" title="Total proceeds, net of discounts">54,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2A3o2L9luYc" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250609__20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z3NLyjFD2Xxd" style="text-align: right" title="Net proceeds, net of discounts">49,439</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">6/20/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250619__20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTk4Jeipz6ac" style="text-align: right" title="Number of common shares issued">917,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250619__20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDZ26zEENMPi" style="text-align: right" title="Total proceeds, net of discounts">44,025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zyCXguAOiG85" style="text-align: right" title="Effective price per share">0.000236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250619__20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zRfe9Uw0YlR3" style="text-align: right" title="Net proceeds, net of discounts">36,912</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">7/2/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250701__20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2Hdiuh0LvU2" style="text-align: right" title="Number of common shares issued">1,157,985</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250701__20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaellQYtJMO" style="text-align: right" title="Total proceeds, net of discounts">37,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZ63rxUUezag" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250701__20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzMTh8ibPRo5" style="text-align: right" title="Net proceeds, net of discounts">30,744</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">7/21/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250720__20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zOWsudMZn49l" style="text-align: right" title="Number of common shares issued">1,368,561</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250720__20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zehT8MHxG6a6" style="text-align: right" title="Total proceeds, net of discounts">43,793</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKVs1XRkVPM9" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250720__20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zf7TG2O3wW42" style="text-align: right" title="Net proceeds, net of discounts">37,732</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">8/22/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250821__20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJnTWO7o2ihg" style="text-align: right" title="Number of common shares issued">426,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250821__20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zL3Lwzpnn1g4" style="text-align: right" title="Total proceeds, net of discounts">13,664</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zGNqH00KdTL6" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250821__20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zy1pfAamQthe" style="text-align: right" title="Net proceeds, net of discounts">11,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">9/4/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250903__20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z6hE55kY2Pp8" style="text-align: right" title="Number of common shares issued">537,621</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250903__20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKMVtZDqhLRf" style="text-align: right" title="Total proceeds, net of discounts">17,204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zy2C1xiP2tO6" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250903__20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaBUtMwSYQS4" style="text-align: right" title="Net proceeds, net of discounts">14,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">9/12/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250911__20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zgWd6bMoYuLj" style="text-align: right" title="Number of common shares issued">428,311</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250911__20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zxxq14B7kPSj" style="text-align: right" title="Total proceeds, net of discounts">13,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z690xaICbTbe" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250911__20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zu3NtC5Mp4xk" style="text-align: right" title="Net proceeds, net of discounts">9,939</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">9/23/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250922__20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zB1ZR1wvGmng" style="text-align: right" title="Number of common shares issued">552,036</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250922__20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zwhVaQOTOaa2" style="text-align: right" title="Total proceeds, net of discounts">17,665</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zAuPT1Dftqdc" style="text-align: right" title="Effective price per share">0.000149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250922__20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z67a5LT6X0Gf" style="text-align: right" title="Net proceeds, net of discounts">13,106</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">10/1/2025</span></td><td> </td> <td id="xdx_98B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250929__20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcznODAqNjx4" style="text-align: right" title="Number of common shares issued">572,888</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250929__20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zyE7tNCNwPi8" style="text-align: right" title="Total proceeds, net of discounts">18,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SaleOfStockPricePerShare_iI_c20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDMm8xgOoCge" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250929__20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zk8AdnyKNMs2" style="text-align: right" title="Net proceeds, net of discounts">13,640</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">10/10/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251009__20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zmQsRLkTHIcl" style="text-align: right" title="Number of common shares issued">576,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251009__20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zNrjQWqtQfyh" style="text-align: right" title="Total proceeds, net of discounts">18,462</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zpZatol6GrHj" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251009__20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zqaJmuT07PQ3" style="text-align: right" title="Net proceeds, net of discounts">13,744</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">10/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251027__20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zxnYigs03aIg" style="text-align: right" title="Number of common shares issued">959,040</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251027__20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zI2E6IvsqcF4" style="text-align: right" title="Total proceeds, net of discounts">17,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zPMYFAAwoeTb" style="text-align: right" title="Effective price per share">0.018320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251027__20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaJxFcs9fOjc" style="text-align: right" title="Net proceeds, net of discounts">15,213</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">11/11/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251110__20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z1RQENUBzDE7" style="text-align: right" title="Number of common shares issued">952,716</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251110__20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zB3A28BmK7a5" style="text-align: right" title="Total proceeds, net of discounts">12,576</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaCiaJQ1JcF" style="text-align: right" title="Effective price per share">0.013200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251110__20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJG25Al0KItk" style="text-align: right" title="Net proceeds, net of discounts">10,648</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">11/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251127__20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zswLjgwdpnz7" style="text-align: right" title="Number of common shares issued">1,053,329</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251127__20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zkVINeD64uPh" style="text-align: right" title="Total proceeds, net of discounts">10,449</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z6axwFtDzkLl" style="text-align: right" title="Effective price per share">0.009920</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251127__20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zdo8XJZptUj3" style="text-align: right" title="Net proceeds, net of discounts">8,624</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">12/9/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251208__20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z9Wu1LL4mbn4" style="text-align: right" title="Number of common shares issued">1,677,132</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251208__20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zkef9InS7UKf" style="text-align: right" title="Total proceeds, net of discounts">50,582</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeu93Qys37Mh" style="text-align: right" title="Effective price per share">0.030160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251208__20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z4507v7q8WV4" style="text-align: right" title="Net proceeds, net of discounts">45,909</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 10pt">12/18/2025</span></td><td style="padding-bottom: 1pt"> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251217__20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zRmREvMKAB2c" style="border-bottom: Black 1pt solid; text-align: right" title="Number of common shares issued">1,246,067</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251217__20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDyGU0v3RVqi" style="border-bottom: Black 1pt solid; text-align: right" title="Total proceeds, net of discounts">24,822</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zsM5fwXMnXH6" style="padding-bottom: 1pt; text-align: right" title="Effective price per share">0.019920</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251217__20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zP7lufLY4ink" style="border-bottom: Black 1pt solid; text-align: right" title="Net proceeds, net of discounts">22,006</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt"> </td> <td id="xdx_98F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z53UwVl2lI5b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of common shares issued">26,498,067</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zO2RXkMKkiD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">1,132,925</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z07a2DrvEs2a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">993,542</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Stock Options</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2025 and 2024, the Company had <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20250101__20251231_zxDC11LJAi0k" title="Outstanding stock options"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20240101__20241231_zgaLwBKp0WEk" title="Outstanding stock options">no</span></span> outstanding stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> 2000000 2000000 0.01 0.01 88335 88335 88335 88335 20000000000 20000000000 0.0001 0.0001 90904606 40500587 <table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfEquityFinancingAgreementEFATableTextBlock_zO7qJdKOyFYa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details - Equity financing EFA)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span id="xdx_8B5_zg7y4pBcJVxh" style="display: none">Schedule of equity financing agreement</span></td><td> </td> <td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Date of Put</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Number of Common <br/>Shares Issued</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total Proceeds,</p> <p style="margin-top: 0; margin-bottom: 0">Net of Discounts</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Effective Price <br/>per Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net Proceeds</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 33%; text-align: center; padding-left: 0.05pt">1/12/2023</td><td style="width: 2%"> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230110__20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFPz8DiG6vt" style="width: 13%; text-align: right" title="Number of common shares issued">64,130,435</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230110__20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zuXNDXuUhhW5" style="width: 13%; text-align: right" title="Total proceeds, net of discounts">400,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockPricePerShare_iI_c20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zK57JBm5LHnh" style="width: 13%; text-align: right" title="Effective price per share">0.006237</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230110__20230112__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z8i3EPzV2PAg" style="width: 13%; text-align: right" title="Net proceeds, net of discounts">370,975</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">1/17/2023*</td><td> </td> <td id="xdx_98B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230116__20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlEXfwgwHJ92" style="text-align: right" title="Number of common shares issued">11,441,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230116__20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zajixsy7Jm1j" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SaleOfStockPricePerShare_iI_c20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhqr28vHqKg9" style="text-align: right" title="Effective price per share">0.008740</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230116__20230117__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zQSrQlBy0MDb" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">1/24/2023</td><td> </td> <td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230123__20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zOzKnMLSsALb" style="text-align: right" title="Number of common shares issued">77,733,861</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230123__20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z5uraPZcPUJ8" style="text-align: right" title="Total proceeds, net of discounts">400,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SaleOfStockPricePerShare_iI_c20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeYdtHmad8Zf" style="text-align: right" title="Effective price per share">0.005146</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230123__20230124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zqU1EqybtMMa" style="text-align: right" title="Total proceeds, net of discounts">370,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2/3/2023</td><td> </td> <td id="xdx_986_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230202__20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfk2mnNZymE6" style="text-align: right" title="Number of common shares issued">61,173,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230202__20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zEAfVW8elTAd" style="text-align: right" title="Total proceeds, net of discounts">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SaleOfStockPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zneCGlmJWNV3" style="text-align: right" title="Effective price per share">0.004904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230202__20230203__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKTsRjzq3yGd" style="text-align: right" title="Total proceeds, net of discounts">277,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">2/17/2023</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230216__20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_znTBpjF5kXA4" style="text-align: right" title="Number of common shares issued">75,447,571</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230216__20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zUr8Gz8C03ia" style="text-align: right" title="Total proceeds, net of discounts">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockPricePerShare_iI_c20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zUpk9dUrOkGi" style="text-align: right" title="Effective price per share">0.003976</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230216__20230217__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zdPYnyKDTjO9" style="text-align: right" title="Total proceeds, net of discounts">277,975</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">3/1/2023</td><td> </td> <td id="xdx_98E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230228__20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zH4RrVOFiSi3" style="text-align: right" title="Number of common shares issued">83,113,044</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230228__20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKxWAXEg4Io2" style="text-align: right" title="Total proceeds, net of discounts">324,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SaleOfStockPricePerShare_iI_c20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zCbK94FDbx73" style="text-align: right" title="Effective price per share">0.003898</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230228__20230301__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zk2mZsKFasqg" style="text-align: right" title="Total proceeds, net of discounts">300,295</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">3/16/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230315__20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zi4U8RAjON0f" style="text-align: right" title="Number of common shares issued">93,165,852</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230315__20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zoVaCd3QVbof" style="text-align: right" title="Total proceeds, net of discounts">254,232</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SaleOfStockPricePerShare_iI_c20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z56ssiDEFL6g" style="text-align: right" title="Effective price per share">0.002729</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230315__20230316__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zC3CM28eAvY3" style="text-align: right" title="Total proceeds, net of discounts">235,410</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">3/30/2023</td><td> </td> <td id="xdx_98A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230329__20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zwkBZYakr7nk" style="text-align: right" title="Number of common shares issued">65,465,384</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230329__20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zxFXV7JQyxpc" style="text-align: right" title="Total proceeds, net of discounts">166,903</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SaleOfStockPricePerShare_iI_c20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfpRwTi5egZb" style="text-align: right" title="Effective price per share">0.002549</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230329__20230330__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zHRvQqOYjUf5" style="text-align: right" title="Total proceeds, net of discounts">154,195</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-left: 0.05pt">4/11/2023</td><td> </td> <td id="xdx_980_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230410__20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIUy8CLw8AJj" style="text-align: right" title="Number of common shares issued">67,462,162</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230410__20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIlXd65iTq3i" style="text-align: right" title="Total proceeds, net of discounts">203,554</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SaleOfStockPricePerShare_iI_c20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZyBLM54dU6j" style="text-align: right" title="Effective price per share">0.003017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230410__20230411__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zHCHWM6Wi3k5" style="text-align: right" title="Total proceeds, net of discounts">188,279</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">4/28/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230427__20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zWpdUz7yvpoc" style="text-align: right" title="Number of common shares issued">91,796,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230427__20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z0ySGHLtxK6c" style="text-align: right" title="Total proceeds, net of discounts">235,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockPricePerShare_iI_c20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zATdUyzSyIzi" style="text-align: right" title="Effective price per share">0.002560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230427__20230428__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYzvd4Fy2NWl" style="text-align: right" title="Total proceeds, net of discounts">208,550</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">6/26/2023</td><td> </td> <td id="xdx_98F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230625__20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zuRYp0WbP8pl" style="text-align: right" title="Number of common shares issued">44,583,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230625__20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zjBeUklViJi2" style="text-align: right" title="Total proceeds, net of discounts">214,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SaleOfStockPricePerShare_iI_c20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z0uVTb4p7Myk" style="text-align: right" title="Effective price per share">0.004800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230625__20230626__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zulgJPcuUVR6" style="text-align: right" title="Total proceeds, net of discounts">141,020</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">7/3/2023</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230702__20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFg8bNeG5Bud" style="text-align: right" title="Number of common shares issued">51,442,308</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230702__20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKXrMfIeNjT5" style="text-align: right" title="Total proceeds, net of discounts">274,058</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SaleOfStockPricePerShare_iI_c20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcWhvI6K9gZi" style="text-align: right" title="Effective price per share">0.004200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230702__20230703__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zH4YZW4LenZ" style="text-align: right" title="Total proceeds, net of discounts">257,020</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">7/10/2023</td><td> </td> <td id="xdx_98F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230709__20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zXjwVHyZQLDh" style="text-align: right" title="Number of common shares issued">28,593,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230709__20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYP4VrLsvVu9" style="text-align: right" title="Total proceeds, net of discounts">91,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockPricePerShare_iI_c20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zmWf7xDfhfZ1" style="text-align: right" title="Effective price per share">0.003200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230709__20230710__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zC9E8jmtRCZ7" style="text-align: right" title="Total proceeds, net of discounts">85,094</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">9/5/2023*</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230904__20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z7OUPGpDihlb" style="text-align: right" title="Number of common shares issued">100,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230904__20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zG0yeehl3RRb" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SaleOfStockPricePerShare_iI_c20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zvR47EsQERMj" style="text-align: right" title="Effective price per share">0.001000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230904__20230905__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbAYymXbkt4l" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">11/7/2023*</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231106__20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zrCUdloqDgMg" style="text-align: right" title="Number of common shares issued">55,555,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231106__20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zAAaWNAVAVXf" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SaleOfStockPricePerShare_iI_c20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbiY9Csxtkel" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231106__20231107__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYy49KkTCAph" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">11/8/2023*</td><td> </td> <td id="xdx_981_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231105__20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zEh8zZVJ6R3" style="text-align: right" title="Number of common shares issued">33,333,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231105__20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZwmXDfhfjBi" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SaleOfStockPricePerShare_iI_c20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zm1kHSy7Pqzg" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231105__20231108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zepbu0SKnTu5" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">11/14/2023</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231113__20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlaD8sUybyLl" style="text-align: right" title="Number of common shares issued">18,997,442</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231113__20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zt7sbbBZO1Ad" style="text-align: right" title="Total proceeds, net of discounts">25,180</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockPricePerShare_iI_c20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z7Rrw2EvIx16" style="text-align: right" title="Effective price per share">0.001325</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231113__20231114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbM6kuY4aGCh" style="text-align: right" title="Total proceeds, net of discounts">22,392</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">11/22/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231121__20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zp1VPpTfIz9b" style="text-align: right" title="Number of common shares issued">29,685,620</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231121__20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSapoKfgqXgk" style="text-align: right" title="Total proceeds, net of discounts">34,717</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SaleOfStockPricePerShare_iI_c20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziHtpjINOsx" style="text-align: right" title="Effective price per share">0.001169</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231121__20231122__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhLRRR40KLFj" style="text-align: right" title="Total proceeds, net of discounts">31,262</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-left: 0.1pt">11/29/2023*</td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231128__20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zj6w6206iPM6" style="text-align: right" title="Number of common shares issued">55,555,555</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231128__20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zMsz01wzHjQk" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockPricePerShare_iI_c20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFEbDC3OdR87" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231128__20231129__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zh00yVH0vmS7" style="text-align: right" title="Total proceeds, net of discounts">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-left: 0.1pt">11/30/2023*</td><td> </td> <td id="xdx_98D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231127__20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z7Z7pF0Y9LVk" style="text-align: right" title="Number of common shares issued">27,777,777</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231127__20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_znfKMXSWIhK1" style="text-align: right" title="Total proceeds, net of discounts">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zddudheSVCvj" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231127__20231130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zVfgudvRcnR9" style="text-align: right" title="Total proceeds, net of discounts">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">12/1/2023*</td><td> </td> <td id="xdx_98C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfVjH04yFsH5" style="text-align: right" title="Number of common shares issued">33,333,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTMHP3kYTW1i" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SaleOfStockPricePerShare_iI_c20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zoW78qh1lZ3a" style="text-align: right" title="Effective price per share">0.000900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zuNhNJ6VGG8l" style="text-align: right" title="Total proceeds, net of discounts">30,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">12/1/2023</td><td> </td> <td id="xdx_987_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_z18fipgEoP26" style="text-align: right" title="Number of common shares issued">51,275,586</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_zCCgVLd2nFHf" style="text-align: right" title="Total proceeds, net of discounts">47,973</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SaleOfStockPricePerShare_iI_c20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_zBnwuq0A8NLk" style="text-align: right" title="Effective price per share">0.000936</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231128__20231201__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementOneMember_zZUkZC5hpDvj" style="text-align: right" title="Total proceeds, net of discounts">43,590</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-left: 0.05pt">12/11/2023</td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231210__20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZ3A6Gyns0sg" style="text-align: right" title="Number of common shares issued">87,136,216</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231210__20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zl2ZUXedX2B2" style="text-align: right" title="Total proceeds, net of discounts">108,019</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SaleOfStockPricePerShare_iI_c20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zYljVjphPhP4" style="text-align: right" title="Effective price per share">0.001240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231210__20231211__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zX0i6zm0Fa8e" style="text-align: right" title="Total proceeds, net of discounts">99,433</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">12/27/2023</td><td> </td> <td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231226__20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zU39qT0RPLz5" style="text-align: right" title="Number of common shares issued">67,522,014</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20231226__20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zF0c7vXUp3c" style="text-align: right" title="Total proceeds, net of discounts">57,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SaleOfStockPricePerShare_iI_c20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaF75dPzhfdf" style="text-align: right" title="Effective price per share">0.000858</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20231226__20231227__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zgeDH4Vb2tEd" style="text-align: right" title="Total proceeds, net of discounts">52,830</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">1/8/2024</td><td> </td> <td id="xdx_98E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240107__20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2xO9OPafu4a" style="text-align: right" title="Number of common shares issued">52,162,997</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20240107__20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziEiusNH2Zb9" style="text-align: right" title="Total proceeds, net of discounts">44,736</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockPricePerShare_iI_c20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zn0HykICGhjk" style="text-align: right" title="Effective price per share">.000858</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20240107__20240108__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zH9mXe9A9a59" style="text-align: right" title="Total proceeds, net of discounts">40,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2/29/2024</td><td> </td> <td id="xdx_983_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240228__20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziXpaE1AUZC8" style="text-align: right" title="Number of common shares issued">178,571,428</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20240228__20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zWFJeKRwp0e8" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zVL3yuj2ucv1" style="text-align: right" title="Effective price per share">.000560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20240228__20240229__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDDOlmXv06D4" style="text-align: right" title="Total proceeds, net of discounts">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">8/19/2024</td><td style="padding-bottom: 1pt"> </td> <td id="xdx_985_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240818__20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zbad6Ws47iCi" style="border-bottom: Black 1pt solid; text-align: right" title="Number of common shares issued">55,555,556</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20240818__20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z1CwCNLK3ZTi" style="border-bottom: Black 1pt solid; text-align: right" title="Total proceeds, net of discounts">40,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--SaleOfStockPricePerShare_iI_c20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z5yUJux9WK3i" style="padding-bottom: 1pt; text-align: right" title="Effective price per share">.0007200</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20240818__20240819__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJJaMfgnCaok" style="border-bottom: Black 1pt solid; text-align: right" title="Total proceeds, net of discounts">36,175</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt"> </td> <td id="xdx_98C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20241231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zBTNhg4wn2fg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of common shares issued">1,662,012,341</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20230101__20241231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zNlUxBAF8Q1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">4,006,781</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20230101__20241231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJewcCCPMGei" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">3,679,025</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 116.5pt; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>2024 Transactions</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On November 6, 2024 the Company entered into an Amendment to the 2023 Equity Financing Agreement with GHS, to which GHS agreed to Purchase $<span id="xdx_906_eus-gaap--PaymentsForRepurchaseOfCommonStock_c20241105__20241106__us-gaap--TransactionTypeAxis__custom--EquityFinancingAgreementMember_zHqpJHV2UB6d" title="Purchase of common stock">30,000,000</span> in shares of our Common Stock over the course of 12 months at <span id="xdx_900_ecustom--MarketPricePercentage_dp_c20241105__20241106__us-gaap--TransactionTypeAxis__custom--EquityFinancingAgreementMember_z6eoSqBioExc" title="Market price percentage">92</span>% of the current market price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The RRA provides that we shall (i) use our best efforts to file with the SEC a Registration Statement within 45 days of the date of the GHS Registration Rights Agreement; and (ii) have the Registration Statement declared effective by the SEC within 30 days after the date the GHS Registration Statement is filed with the SEC, but in no event more than 90 days after the GHS Registration Statement is filed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The below table of puts from 1/6/2025 through 12/18/2025 were made by the Company under the EFA amended in November 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details - Equity financing EFA)"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Date of Put</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of Common <br/> Shares Issued</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Total Proceeds,</p> <p style="margin-top: 0; margin-bottom: 0">Net of Discounts</p></td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Effective Price <br/> per Share</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net Proceeds</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 33%; text-align: center"><span style="font-size: 10pt">1/6/2025</span></td><td style="width: 2%"> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250105__20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z1n74Z4vPzB7" style="width: 13%; text-align: right" title="Number of common shares issued">183,202</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250105__20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSN2LA7A7Vc7" style="width: 13%; text-align: right" title="Total proceeds, net of discounts">23,450</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zvT8PblXk9V4" style="width: 13%; text-align: right" title="Effective price per share">0.000640</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250105__20250106__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zd1VhRevJZh6" style="width: 13%; text-align: right" title="Net proceeds, net of discounts">20,783</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">1/14/2025</span></td><td> </td> <td id="xdx_988_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250113__20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zz4AGp0ujkR2" style="text-align: right" title="Number of common shares issued">256,077</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250113__20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zllBVaXdNv4d" style="text-align: right" title="Total proceeds, net of discounts">32,778</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SaleOfStockPricePerShare_iI_c20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlucLJpbZBD9" style="text-align: right" title="Effective price per share">0.000640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250113__20250114__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zMccK13I3Cn1" style="text-align: right" title="Net proceeds, net of discounts">29,458</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">1/24/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250123__20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFU4aIBB1Otk" style="text-align: right" title="Number of common shares issued">395,308</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250123__20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zadRVEtid6C7" style="text-align: right" title="Total proceeds, net of discounts">50,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SaleOfStockPricePerShare_iI_c20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeW9KS6xgxn2" style="text-align: right" title="Effective price per share">0.000640</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250123__20250124__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSoK5jYcoEbg" style="text-align: right" title="Net proceeds, net of discounts">46,050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">1/30/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250129__20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z4TDPbgpGAbe" style="text-align: right" title="Number of common shares issued">695,043</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250129__20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zM5omxAp6t9j" style="text-align: right" title="Total proceeds, net of discounts">55,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zUobzYxgPW3a" style="text-align: right" title="Effective price per share">0.000400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250129__20250130__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zVT74VaRf2fl" style="text-align: right" title="Net proceeds, net of discounts">50,686</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">2/7/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250206__20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zEMI3qzzb9u1" style="text-align: right" title="Number of common shares issued">622,323</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250206__20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zqWVhwCSxGm" style="text-align: right" title="Total proceeds, net of discounts">49,786</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJkIzZVH7KX9" style="text-align: right" title="Effective price per share">0.000399</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250206__20250207__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfhaVv5e5uX6" style="text-align: right" title="Net proceeds, net of discounts">45,276</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">2/18/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250217__20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIyDGowsO4ql" style="text-align: right" title="Number of common shares issued">657,228</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250217__20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z68Yb00psc7e" style="text-align: right" title="Total proceeds, net of discounts">42,063</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcxBXT9QJn52" style="text-align: right" title="Effective price per share">0.000320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250217__20250218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDeKVNIZACK8" style="text-align: right" title="Net proceeds, net of discounts">38,093</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">2/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250227__20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlZDbD57VO89" style="text-align: right" title="Number of common shares issued">710,373</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250227__20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zb7Zr6MnzLLj" style="text-align: right" title="Total proceeds, net of discounts">34,098</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z5JNqrXZYJDf" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250227__20250228__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zE88TXJW3yUd" style="text-align: right" title="Net proceeds, net of discounts">30,686</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">3/10/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250309__20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhauAFloRkh7" style="text-align: right" title="Number of common shares issued">663,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250309__20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zT4JeKtaHZJ7" style="text-align: right" title="Total proceeds, net of discounts">31,848</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIDAC8y5jPPh" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250309__20250310__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z3xRTRMdiIO4" style="text-align: right" title="Net proceeds, net of discounts">25,594</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">3/18/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250317__20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zCNAW9G1zgce" style="text-align: right" title="Number of common shares issued">1,122,820</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250317__20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zv1CsGHLRmtk" style="text-align: right" title="Total proceeds, net of discounts">53,895</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzsRI6NnEHFh" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250317__20250318__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zfuffRo0rZ94" style="text-align: right" title="Net proceeds, net of discounts">40,098</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">3/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250327__20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zBUgv0gaDcyh" style="text-align: right" title="Number of common shares issued">1,019,222</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250327__20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcR8Y7uMYOJk" style="text-align: right" title="Total proceeds, net of discounts">65,230</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlxdpKboR5k4" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250327__20250328__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzzVrvUlY7eh" style="text-align: right" title="Net proceeds, net of discounts">59,364</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">4/4/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250403__20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ziq6dmlsiDG1" style="text-align: right" title="Number of common shares issued">653,076</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250403__20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zA2tfP5rnWdd" style="text-align: right" title="Total proceeds, net of discounts">41,797</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_ztS4dD6nkyE2" style="text-align: right" title="Effective price per share">0.000320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250403__20250404__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zhW4MWFOQvh9" style="text-align: right" title="Net proceeds, net of discounts">37,846</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">4/14/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250413__20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z9Ge119ZX5Vi" style="text-align: right" title="Number of common shares issued">895,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250413__20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zBOIi4nVjHeh" style="text-align: right" title="Total proceeds, net of discounts">42,963</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zI3fj6iJK6ii" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250413__20250414__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcLnPZzDzTv4" style="text-align: right" title="Net proceeds, net of discounts">38,931</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">4/23/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250422__20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zc4XGjdvpoyh" style="text-align: right" title="Number of common shares issued">906,671</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250422__20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zirCOshGxgEj" style="text-align: right" title="Total proceeds, net of discounts">58,027</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zmYUAdt4rN89" style="text-align: right" title="Effective price per share">0.000320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250422__20250423__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z6BD69szCEZb" style="text-align: right" title="Net proceeds, net of discounts">52,940</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">5/1/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250430__20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzkzz5KYDBj6" style="text-align: right" title="Number of common shares issued">1,126,922</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250430__20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zlcfCWfJBEAi" style="text-align: right" title="Total proceeds, net of discounts">46,844</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTSFTOLB3d9i" style="text-align: right" title="Effective price per share">0.000249</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250430__20250501__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zd5aiBJitg95" style="text-align: right" title="Net proceeds, net of discounts">42,540</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">5/9/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250508__20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zSM9QolWLT04" style="text-align: right" title="Number of common shares issued">941,402</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250508__20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zFS9T6HjoSJd" style="text-align: right" title="Total proceeds, net of discounts">43,273</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zOumhNprlaZj" style="text-align: right" title="Effective price per share">0.000190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250508__20250509__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zHc5KbDVKQ7h" style="text-align: right" title="Net proceeds, net of discounts">39,219</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">5/21/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250520__20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeHw1XWmwI4f" style="text-align: right" title="Number of common shares issued">949,987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250520__20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zXH2z14TyDrc" style="text-align: right" title="Total proceeds, net of discounts">30,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z9HaNVeDTQ9a" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250520__20250521__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2iJMt9ciVNl" style="text-align: right" title="Net proceeds, net of discounts">27,247</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">5/30/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250529__20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zjMps2n2YHJ8" style="text-align: right" title="Number of common shares issued">1,127,583</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250529__20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcDbZFUlcLch" style="text-align: right" title="Total proceeds, net of discounts">36,083</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTxcI59vZcNe" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250529__20250530__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zNnrf6yXzPx1" style="text-align: right" title="Net proceeds, net of discounts">32,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">6/10/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250609__20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zIyCkxLNhlR7" style="text-align: right" title="Number of common shares issued">1,130,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250609__20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zz2dlXNcqWtc" style="text-align: right" title="Total proceeds, net of discounts">54,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2A3o2L9luYc" style="text-align: right" title="Effective price per share">0.000240</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250609__20250610__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z3NLyjFD2Xxd" style="text-align: right" title="Net proceeds, net of discounts">49,439</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">6/20/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250619__20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zTk4Jeipz6ac" style="text-align: right" title="Number of common shares issued">917,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250619__20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDZ26zEENMPi" style="text-align: right" title="Total proceeds, net of discounts">44,025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zyCXguAOiG85" style="text-align: right" title="Effective price per share">0.000236</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250619__20250620__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zRfe9Uw0YlR3" style="text-align: right" title="Net proceeds, net of discounts">36,912</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">7/2/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250701__20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z2Hdiuh0LvU2" style="text-align: right" title="Number of common shares issued">1,157,985</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250701__20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaellQYtJMO" style="text-align: right" title="Total proceeds, net of discounts">37,055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zZ63rxUUezag" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250701__20250702__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zzMTh8ibPRo5" style="text-align: right" title="Net proceeds, net of discounts">30,744</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">7/21/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250720__20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zOWsudMZn49l" style="text-align: right" title="Number of common shares issued">1,368,561</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250720__20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zehT8MHxG6a6" style="text-align: right" title="Total proceeds, net of discounts">43,793</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKVs1XRkVPM9" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250720__20250721__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zf7TG2O3wW42" style="text-align: right" title="Net proceeds, net of discounts">37,732</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">8/22/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250821__20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJnTWO7o2ihg" style="text-align: right" title="Number of common shares issued">426,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250821__20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zL3Lwzpnn1g4" style="text-align: right" title="Total proceeds, net of discounts">13,664</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zGNqH00KdTL6" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250821__20250822__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zy1pfAamQthe" style="text-align: right" title="Net proceeds, net of discounts">11,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">9/4/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250903__20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z6hE55kY2Pp8" style="text-align: right" title="Number of common shares issued">537,621</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250903__20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zKMVtZDqhLRf" style="text-align: right" title="Total proceeds, net of discounts">17,204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zy2C1xiP2tO6" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250903__20250904__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaBUtMwSYQS4" style="text-align: right" title="Net proceeds, net of discounts">14,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">9/12/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250911__20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zgWd6bMoYuLj" style="text-align: right" title="Number of common shares issued">428,311</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250911__20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zxxq14B7kPSj" style="text-align: right" title="Total proceeds, net of discounts">13,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z690xaICbTbe" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250911__20250912__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zu3NtC5Mp4xk" style="text-align: right" title="Net proceeds, net of discounts">9,939</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">9/23/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250922__20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zB1ZR1wvGmng" style="text-align: right" title="Number of common shares issued">552,036</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250922__20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zwhVaQOTOaa2" style="text-align: right" title="Total proceeds, net of discounts">17,665</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zAuPT1Dftqdc" style="text-align: right" title="Effective price per share">0.000149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250922__20250923__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z67a5LT6X0Gf" style="text-align: right" title="Net proceeds, net of discounts">13,106</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">10/1/2025</span></td><td> </td> <td id="xdx_98B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250929__20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zcznODAqNjx4" style="text-align: right" title="Number of common shares issued">572,888</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250929__20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zyE7tNCNwPi8" style="text-align: right" title="Total proceeds, net of discounts">18,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SaleOfStockPricePerShare_iI_c20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDMm8xgOoCge" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250929__20251002__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zk8AdnyKNMs2" style="text-align: right" title="Net proceeds, net of discounts">13,640</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">10/10/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251009__20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zmQsRLkTHIcl" style="text-align: right" title="Number of common shares issued">576,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251009__20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zNrjQWqtQfyh" style="text-align: right" title="Total proceeds, net of discounts">18,462</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zpZatol6GrHj" style="text-align: right" title="Effective price per share">0.000160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251009__20251010__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zqaJmuT07PQ3" style="text-align: right" title="Net proceeds, net of discounts">13,744</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">10/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251027__20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zxnYigs03aIg" style="text-align: right" title="Number of common shares issued">959,040</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251027__20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zI2E6IvsqcF4" style="text-align: right" title="Total proceeds, net of discounts">17,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zPMYFAAwoeTb" style="text-align: right" title="Effective price per share">0.018320</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251027__20251028__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaJxFcs9fOjc" style="text-align: right" title="Net proceeds, net of discounts">15,213</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">11/11/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251110__20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z1RQENUBzDE7" style="text-align: right" title="Number of common shares issued">952,716</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251110__20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zB3A28BmK7a5" style="text-align: right" title="Total proceeds, net of discounts">12,576</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zaCiaJQ1JcF" style="text-align: right" title="Effective price per share">0.013200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251110__20251111__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zJG25Al0KItk" style="text-align: right" title="Net proceeds, net of discounts">10,648</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-size: 10pt">11/28/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251127__20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zswLjgwdpnz7" style="text-align: right" title="Number of common shares issued">1,053,329</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251127__20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zkVINeD64uPh" style="text-align: right" title="Total proceeds, net of discounts">10,449</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z6axwFtDzkLl" style="text-align: right" title="Effective price per share">0.009920</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251127__20251128__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zdo8XJZptUj3" style="text-align: right" title="Net proceeds, net of discounts">8,624</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center"><span style="font-size: 10pt">12/9/2025</span></td><td> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251208__20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z9Wu1LL4mbn4" style="text-align: right" title="Number of common shares issued">1,677,132</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251208__20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zkef9InS7UKf" style="text-align: right" title="Total proceeds, net of discounts">50,582</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zeu93Qys37Mh" style="text-align: right" title="Effective price per share">0.030160</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251208__20251209__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z4507v7q8WV4" style="text-align: right" title="Net proceeds, net of discounts">45,909</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 10pt">12/18/2025</span></td><td style="padding-bottom: 1pt"> </td> <td id="xdx_982_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251217__20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zRmREvMKAB2c" style="border-bottom: Black 1pt solid; text-align: right" title="Number of common shares issued">1,246,067</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20251217__20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zDyGU0v3RVqi" style="border-bottom: Black 1pt solid; text-align: right" title="Total proceeds, net of discounts">24,822</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_985_eus-gaap--SaleOfStockPricePerShare_iI_c20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zsM5fwXMnXH6" style="padding-bottom: 1pt; text-align: right" title="Effective price per share">0.019920</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20251217__20251218__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zP7lufLY4ink" style="border-bottom: Black 1pt solid; text-align: right" title="Net proceeds, net of discounts">22,006</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt"> </td> <td id="xdx_98F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z53UwVl2lI5b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of common shares issued">26,498,067</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--GrossProceedsFromIssuanceOfCommonStockNetOfDiscounts_pp0p0_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_zO2RXkMKkiD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">1,132,925</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--EquityFinancingAgreementMember_z07a2DrvEs2a" style="border-bottom: Black 2.5pt double; text-align: right" title="Total proceeds, net of discounts">993,542</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Stock Options</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of December 31, 2025 and 2024, the Company had <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20250101__20251231_zxDC11LJAi0k" title="Outstanding stock options"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_do_c20240101__20241231_zgaLwBKp0WEk" title="Outstanding stock options">no</span></span> outstanding stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> 64130435 400000 0.006237 370975 11441647 100000 0.008740 100000 77733861 400000 0.005146 370975 61173706 300000 0.004904 277975 75447571 300000 0.003976 277975 83113044 324000 0.003898 300295 93165852 254232 0.002729 235410 65465384 166903 0.002549 154195 67462162 203554 0.003017 188279 91796875 235000 0.002560 208550 44583334 214000 0.004800 141020 51442308 274058 0.004200 257020 28593750 91500 0.003200 85094 100000000 100000 0.001000 100000 55555555 50000 0.000900 50000 33333333 30000 0.000900 30000 18997442 25180 0.001325 22392 29685620 34717 0.001169 31262 55555555 50000 0.000900 50000 27777777 25000 0.000900 25000 33333333 30000 0.000900 30000 51275586 47973 0.000936 43590 87136216 108019 0.001240 99433 67522014 57909 0.000858 52830 52162997 44736 0.000858 40580 178571428 100000 0.000560 100000 55555556 40000 0.0007200 36175 1662012341 4006781 3679025 30000000 0.92 183202 23450 0.000640 20783 256077 32778 0.000640 29458 395308 50619 0.000640 46050 695043 55603 0.000400 50686 622323 49786 0.000399 45276 657228 42063 0.000320 38093 710373 34098 0.000240 30686 663499 31848 0.000240 25594 1122820 53895 0.000240 40098 1019222 65230 0.000240 59364 653076 41797 0.000320 37846 895072 42963 0.000240 38931 906671 58027 0.000320 52940 1126922 46844 0.000249 42540 941402 43273 0.000190 39219 949987 30400 0.000160 27247 1127583 36083 0.000160 32532 1130457 54262 0.000240 49439 917188 44025 0.000236 36912 1157985 37055 0.000160 30744 1368561 43793 0.000160 37732 426994 13664 0.000160 11067 537621 17204 0.000160 14200 428311 13706 0.000160 9939 552036 17665 0.000149 13106 572888 18333 0.000160 13640 576942 18462 0.000160 13744 959040 17570 0.018320 15213 952716 12576 0.013200 10648 1053329 10449 0.009920 8624 1677132 50582 0.030160 45909 1246067 24822 0.019920 22006 26498067 1132925 993542 0 0 <p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zeWhW7bXa7Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 – <span id="xdx_823_zoIf4Pns0Td6">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The domestic and foreign components of loss before (benefit) provision for income taxes were as follows:</span></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zD6IpOGHKI44" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BC_z1clsVrEazk9" style="display: none">Schedule of provision for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20250101__20251231_zAzncwgoKZ6d" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20240101__20241231_zh6mfl3k2ma6" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzvUm_zX9KBDgnnXq" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Domestic:</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(11,676,768</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(11,676,768</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzvUm_zRlj4rGP7QCe" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Foreign:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,133,368</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,133,368</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzvUm_zzSLOTL2Ee08" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; text-align: left; padding-bottom: 2.5pt"><b style="display: none">Total income (loss) before income taxes</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(18,810,136</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(18,810,136</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Provision for Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense (benefit) consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_407_eus-gaap--IncomeTaxesPaidNetAbstract_iB_zZMLUlEUMNwg" style="vertical-align: bottom"> <td>Current:</td><td> </td> <td colspan="3" id="xdx_498_20250101__20251231_zfqQpYyMJK55" style="text-align: center"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxPaidFederalAfterRefundReceived_d0_zSRU5pHUEIuj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Federal</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxPaidStateAndLocalAfterRefundReceived_d0_zWLjtCFd1Hu4" style="vertical-align: bottom; background-color: White"> <td>State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxPaidForeignAfterRefundReceived_d0_zA8TWOBZKBFh" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Foreign</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxesPaidNet_d0_zrztEOi20dIc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Total Current</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_iB_zsH1Z1YTpo42" style="vertical-align: bottom; background-color: White"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_d0_zBoryTkJokek" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_d0_zdRcY5PdFQ36" style="vertical-align: bottom; background-color: White"> <td>State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_zcbPX8jfXjX" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Foreign</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,554</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxExpenseBenefit_iN_di_zF3ak5RMrx8g" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Total Deferred</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: right">(5,554</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxExpenseBenefit_zVnkbyZOYJ89" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Total Provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,554</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zlc6vavsml4h" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded no income tax expense or benefit for the year ended December 31, 2025 due to the generation of losses and the application of a full valuation allowance against deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effective Tax Rate Reconciliation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reconciliation of income taxes computed at the U.S. federal statutory rate to the reported income tax provision is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zAWCP6DpSDX4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax rate)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zIuK3g8t9Hva">Schedule effective income tax reconciliation</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Pretax Income</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tax benefit at 21% (statutory rate)</p></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20250101__20251231_zhQDoAP0Lsgd" style="width: 13%; text-align: right">(3,952,229</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_marate2024_c20240101__20241231_z6wd9lnyDDc8">-21.00</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">State taxes, net of federal benefit</p></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_dxL_c20250101__20251231_zjxqzkTaGppl" style="text-align: right" title="::XDX::%280%29">(<span style="-sec-ix-hidden: xdx2ixbrl1872">–</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp0_c20240101__20241231_zvLJm9iRerFe">–</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Foreign rate differential</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_dxL_c20250101__20251231_zD2YwbIDCF9l" style="text-align: right" title="::XDX::%280%29">(<span style="-sec-ix-hidden: xdx2ixbrl1874">–</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp0_c20240101__20241231_z10bOsGwcwUf">–</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Valuation allowance</p></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20250101__20251231_zfUB6IIe0dCd" style="text-align: right">3,952,229</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240101__20241231_z9obz11EHaz9">21</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationOtherAdjustments_d0_c20250101__20251231_zXKffqD92eH1" style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp0_c20240101__20241231_zZuOXPZS9628">–</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20251231_zcdxzejpJZoi" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp0_mtrate2024_c20240101__20241231_zXxACYt9llQh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">0.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A0_z5MXvpqnquii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred tax Assets and Valuation Allowance</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has deferred tax assets primarily related to net operating loss carryforwards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has determined that it is more likely than not that these deferred tax assets will not be realized due to a lack of sufficient positive evidence, including cumulative losses. Accordingly, the Company has recorded a full valuation allowance against its net deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Net Operating Losses</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As December 31, 2025, the Company has a net operating loss (“NOL”) carryforward of approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_c20251231_z3TSZJTtScRf">26,485,942</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">U.S. federal NOLs may be carried forward indefinitely.</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Utilization is limited to 80% of taxable income in future periods</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">The NOLs may be subject to limitation under Internal Revenue Cide Section 382 in the event of an ownership change.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Uncertain Tax Positions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company did <span id="xdx_908_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20251231_zpM7gLX11HZ3">no</span>t have any material unrecognized tax benefits as of December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company files income tax returns in the United States and foreign jurisdictions. Tax years 2022 through 2025 remain subject to examination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Foreign Earnings</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has not recorded a deferred tax liability related to outside basis differences in foreign subsidiaries, as such amounts are not material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest accrued on uncertain tax positions as well as interest received from favorable tax settlements within interest expense. The Company recognizes penalties accrued on unrecognized tax benefits within selling, general and administrative expenses. As of December 31, 2025 and 2024 the Company had no uncertain tax positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company does not anticipate any significant changes to the total amounts of unrecognized tax benefits in the next twelve months. The Company files income tax returns in New Brunswick, Canada, and the U.S. federal, New York, and Delaware and the UK jurisdictions. Tax years 2012 to current remain open to examination by Canadian authorities; the tax year 2020 remains open to examination by U.S. authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 16 – SEGMENT INFORMATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates as a <span id="xdx_903_eus-gaap--NumberOfReportableSegments_dxL_uInteger_c20250101__20251231_zbYZ5W71NTx7" title="::XDX::1"><span id="xdx_904_eus-gaap--NumberOfOperatingSegments_dxL_uInteger_c20250101__20251231_zjD6cyuSvx4a" title="::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl1888"><span style="-sec-ix-hidden: xdx2ixbrl1889">single</span></span></span></span> operating and reportable segment. The Company’s Chief Operating Decision Maker (“CODM”), the Chief Executive Officer, reviews financial information on a fully consolidated basis. There are no distinct operating segments with separate financial performance metrics, resource allocation decisions, or discrete profit/loss evaluations. Revenue is modest and primarily service-based, with ongoing net losses, all managed holistically. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zD6IpOGHKI44" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BC_z1clsVrEazk9" style="display: none">Schedule of provision for income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20250101__20251231_zAzncwgoKZ6d" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20240101__20241231_zh6mfl3k2ma6" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2025</b></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzvUm_zX9KBDgnnXq" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%">Domestic:</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(11,676,768</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(11,676,768</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzvUm_zRlj4rGP7QCe" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Foreign:</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,133,368</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,133,368</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzvUm_zzSLOTL2Ee08" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-decoration: none; text-align: left; padding-bottom: 2.5pt"><b style="display: none">Total income (loss) before income taxes</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(18,810,136</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(18,810,136</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Provision for Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense (benefit) consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr id="xdx_407_eus-gaap--IncomeTaxesPaidNetAbstract_iB_zZMLUlEUMNwg" style="vertical-align: bottom"> <td>Current:</td><td> </td> <td colspan="3" id="xdx_498_20250101__20251231_zfqQpYyMJK55" style="text-align: center"> </td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxPaidFederalAfterRefundReceived_d0_zSRU5pHUEIuj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%">Federal</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxPaidStateAndLocalAfterRefundReceived_d0_zWLjtCFd1Hu4" style="vertical-align: bottom; background-color: White"> <td>State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxPaidForeignAfterRefundReceived_d0_zA8TWOBZKBFh" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Foreign</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxesPaidNet_d0_zrztEOi20dIc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Total Current</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_iB_zsH1Z1YTpo42" style="vertical-align: bottom; background-color: White"> <td>Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_d0_zBoryTkJokek" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_d0_zdRcY5PdFQ36" style="vertical-align: bottom; background-color: White"> <td>State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_zcbPX8jfXjX" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Foreign</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,554</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxExpenseBenefit_iN_di_zF3ak5RMrx8g" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Total Deferred</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: right">(5,554</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxExpenseBenefit_zVnkbyZOYJ89" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Total Provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,554</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -11676768 -11676768 -7133368 -7133368 -18810136 -18810136 0 0 0 0 0 0 -5554 5554 5554 <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zAWCP6DpSDX4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax rate)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zIuK3g8t9Hva">Schedule effective income tax reconciliation</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of Pretax Income</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tax benefit at 21% (statutory rate)</p></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20250101__20251231_zhQDoAP0Lsgd" style="width: 13%; text-align: right">(3,952,229</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_marate2024_c20240101__20241231_z6wd9lnyDDc8">-21.00</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">State taxes, net of federal benefit</p></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_dxL_c20250101__20251231_zjxqzkTaGppl" style="text-align: right" title="::XDX::%280%29">(<span style="-sec-ix-hidden: xdx2ixbrl1872">–</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp0_c20240101__20241231_zvLJm9iRerFe">–</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Foreign rate differential</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_dxL_c20250101__20251231_zD2YwbIDCF9l" style="text-align: right" title="::XDX::%280%29">(<span style="-sec-ix-hidden: xdx2ixbrl1874">–</span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp0_c20240101__20241231_z10bOsGwcwUf">–</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Valuation allowance</p></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20250101__20251231_zfUB6IIe0dCd" style="text-align: right">3,952,229</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240101__20241231_z9obz11EHaz9">21</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationOtherAdjustments_d0_c20250101__20251231_zXKffqD92eH1" style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp0_c20240101__20241231_zZuOXPZS9628">–</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20251231_zcdxzejpJZoi" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp0_mtrate2024_c20240101__20241231_zXxACYt9llQh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">0.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> -3952229 0.2100 0 0 3952229 0.21 0 0 0 0.000 26485942 0 <p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_znDVKqsCUtY2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 17 – <span id="xdx_82E_zXbEInYYTHaa">COMMITMENTS AND CONTINGENCIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Legal Matters</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Carebourn Capital, L.P. v. DarkPulse, Inc.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about January 29, 2021, Carebourn Capital, L.P. (“<b>Carebourn</b>”) commenced an action against the Company in Minnesota State Court. Carebourn alleged that the Company was in breach of two convertible promissory notes sold to Carebourn on or about July 17, 2018 and July 24, 2018. Thereafter, the Company answered Carebourn’s complaint and asserted counterclaims under the Minnesota Securities Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about November 17, 2023, the State Court ruled in the Company’s favor on, among other things, its counterclaim for damages pursuant to Minnesota Securities Act and awarded the Company damages in the amount of $124,012.91, attorney’s fees in the amount of $239,923.33 and costs in the amount of $23,757.24 (or a total award in the amount of $387,693.48).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of the date hereof, the final judgment remains unsatisfied by Carebourn. DarkPulse intends to continue to exercise all legal rights and remedies available to it to collect the amounts awarded should Carebourn fail to voluntarily pay the same.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>More Capital, LLC v. DarkPulse, Inc. et al</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about June 29, 2021, More Capital, LLC (“<b>More</b>”) commenced an action against the Company in Minnesota State Court. More alleged that the Company was in breach of a certain securities purchase agreement and convertible promissory note sold to More on or about August 20, 2018. Thereafter, the Company answered More’s complaint and asserted counterclaims under the Minnesota Securities Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about December 11, 2023, the Minnesota State Court ruled in the Company’s favor on, among other things, its counterclaim for damages pursuant to Minnesota Securities Act and awarded the Company damages in the amount of $300,809.39, attorney’s fees in the amount of $110,029.00 and costs in the amount of $210.25 (or a total award in the amount of $412,048.64).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of the date hereof, the final judgment remains unsatisfied by More. DarkPulse intends to continue to exercise all legal rights and remedies available to it to collect the amounts awarded should More fail to voluntarily pay the same.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Carebourn Capital et al v. Standard Registrar and Transfer et al</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about May 20, 2022, the Carebourn Capital, L.P. (“<b>Carebourn</b>”) and More Capital, LLC (“<b>More</b>,” and together with Carebourn, the “<b>Noteholders</b>”) commenced an action against the Company, certain members of the Company’s executive team and board of directors and Standard Registrar and Transfer Company, Inc., the Company’s transfer agent, in the United States District Court for the District of Utah. The Noteholders’ complaint alleged various causes of action arising from certain securities purchase agreements and convertible promissory notes the Company sold to the Noteholders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about November 1, 2023, the Noteholders moved to dismiss the action.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about November 2, 2023, the Company moved for sanctions against the Noteholders and their counsel of record.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about December 4, 2023, the Court entered an order granting dismissal of the Noteholders’ claims with prejudice. The Court acknowledged that notwithstanding its dismissal of the Noteholders’ claims, the Court continues to retain jurisdiction over the Noteholders because of DarkPulse’s pending motion for sanctions against the Noteholders and their attorneys.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On September 10, 2024, the Court entered an order granting in part the Company’s motion for sanctions against the Noteholders and their counsel of record.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On July 15, 2025, the Court entered an order ordering the Noteholders and their counsel to pay the sum of $70,840 to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On September 30, 2025, the Court entered Final Judgment in this matter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.3pt 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of the date hereof, the Noteholders and their counsel have not paid the awarded amount to the Company. DarkPulse intends to continue to exercise all legal rights and remedies available to it to collect the amounts awarded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>DarkPulse, Inc. v. FirstFire Global Opportunities Fund, LLC, et al</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about December 31, 2021, the Company commenced an action against FirstFire Global Opportunities Fund, LLC (“<b>FirstFire</b>”) and its control person, Eli Fireman (“<b>Fireman</b>,” and together with FirstFire, the “<b>FirstFire Defendants</b>”), in the United States District Court for the Southern District of New York.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about May 5, 2022, the Company amended its complaint against the FirstFire Defendants. The amended complaint alleges that the FirstFire Defendants were liable to the Company for rescission of certain convertible promissory notes and transitions effected thereunder and damages pursuant to the Securities Exchange Act of 1934 (“<b>Exchange Act</b>”) and Racketeer Influenced and Corrupt Organizations Act (“<b>RICO</b>”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about January 17, 2023, the Court granted the FirstFire Defendants’ motion to dismiss the Company’s operative pleading. Later during the same day, the Company appealed the Court’s decision to the United States Court of Appeals for the Second Circuit (“<b>Second Circuit</b>”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On March 28, 2024, the Second Circuit issued its decision and found that the District Court</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 3%">(a)</td><td style="text-align: justify; width: 97%">properly found that the Delaware forum-selection clause was enforceable but, thereafter,</td></tr><tr style="vertical-align: top"> <td>(b)</td><td style="text-align: justify">improperly made a ruling on the merits of the Company’s claims for relief. As a result, the Second Circuit affirmed the District Court’s decision in part, vacated in part and remanded the case back to the District Court for transferring to the United States District Court for the District of Delaware.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On September 30, 2025, the Delaware Court granted the FirstFire Defendants’ Motion to Dismiss. On October 14, 2025, the Company filed a Motion for Reconsideration of the Delaware Court’s September 30th decision.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of the date hereof, the Delaware Court has not ruled on DarkPulse’s Motion for Reconsideration. The Company remains committed to actively litigating its claims for relief against the FirstFire Defendants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>DarkPulse, Inc., et al v. Crown Bridge Partners, LLC, et al</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 18.3pt 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about September 23, 2022, the Company, Social Life Network, Inc. and Redhawk Holdings Corp. (together, the “Crown Bridge Plaintiffs”) commenced an action against Crown Bridge Partners, LLC (“Crown Bridge”) and its control persons, Soheil Ahdoot and Sepas Ahdoot (collectively, the “Crown Bridge Defendants”) in the United States District Court for the Southern District of New York. The complaint alleges that the Crown Bridge Defendants are liable to each of the plaintiffs for damages pursuant to the Racketeer Influenced and Corrupt Organizations Act (“RICO”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On or about September 29, 2023, the Court granted the Crown Bridge Defendants’ motion to dismiss the plaintiffs’ complaint.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On October 23, 2023, the plaintiffs appealed the Court’s decision to the United States Court of Appeals for the Second Circuit (“<b>Second Circuit</b>”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On August 19, 2024, the Second Circuit issued its decision and found that the District Court erred when granting the Crown Bridge Defendants’ motion to dismiss. As a result, the Second Circuit vacated the District Court’s decision and remanded the case back to the District Court for further proceedings consistent with its decision.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On July 16, 2024, the parties submitted final briefing on their respective motions for summary judgment and/or dismissal to the Court.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As of the date hereof, the Court has not issued a ruling on the parties’ respective motions. The Company remains committed to actively litigating its claims for relief against the Crown Bridge Defendants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Unasserted Matters</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We are unfamiliar with any unasserted claims held by the Company as of December 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In addition to the foregoing Legal Proceedings, we are also actively investigating potential legal claims, including but not limited to stock fraud, market manipulation, and/or defamation, against certain Twitter accounts, websites, and social media channels. The investigation is ongoing and should potential claims be identified, we will evaluate commencing formal litigation proceedings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">From time to time, we may become involved in litigation relating to claims arising out of our operations in the normal course of business. We are not currently involved in any pending legal proceeding or litigation and, to the best of our knowledge, no governmental authority is contemplating any proceeding to which we are a party or to which any of our properties is subject, which would reasonably be likely to have a material adverse effect on our business, financial condition and operating results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zhDj1SVDtGs9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 18 – <span id="xdx_825_z2f1zCtpBOWk">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 5.4pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a) affiliates of the Company; b) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the years ended December 31, 2025 and 2024, certain executives of the Company received $<span id="xdx_90E_eus-gaap--NoninterestExpenseDirectorsFees_c20250101__20251231__dei--LegalEntityAxis__custom--OptilanMember_zmfBo0r95hTd" title="Directors fees">0</span> and $<span id="xdx_90F_eus-gaap--NoninterestExpenseDirectorsFees_c20240101__20241231__dei--LegalEntityAxis__custom--OptilanMember_zf0wwgVtmgr" title="Directors fees">0</span> respectively, in Directors fees from Optilan for being members of Optilan’s Board of Directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Remote Intelligence and Wildlife Specialists Loan Payables</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">RI has a loan payable with the former majority shareholder, who is a shareholder in the Company after the acquisition of 60% of RI’s membership interests. The loan is unsecured, non-interest bearing and due on demand. As of both years ended 2025 and 2024, the outstanding balance was $<span id="xdx_902_eus-gaap--LoansPayable_iI_pp0p0_c20251231__srt--CounterpartyNameAxis__custom--RemoteIntelligenceMember_zcwXs8if96s7" title="Loans payable"><span id="xdx_90E_eus-gaap--LoansPayable_iI_pp0p0_c20241231__srt--CounterpartyNameAxis__custom--RemoteIntelligenceMember_zYyC8fr8ahY6" title="Loans payable">226,247</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">WS has a loan payable with the former majority shareholder, who is a shareholder in the Company after the acquisition of 60% of WS’s membership interests. The loan is unsecured, non-interest bearing and due on demand. As of both years ended 2025 and 2024, the outstanding balance was $<span id="xdx_900_eus-gaap--LoansPayable_c20251231__srt--CounterpartyNameAxis__custom--WildlifeSpecialistsMember_pp0p0" title="Loans payable"><span id="xdx_900_eus-gaap--LoansPayable_iI_pp0p0_c20241231__srt--CounterpartyNameAxis__custom--WildlifeSpecialistsMember_zrjKvCcEjVz1" title="Loans payable">135,500</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt"></p> 0 0 226247 226247 135500 135500 <p id="xdx_80F_eus-gaap--SubsequentEventsTextBlock_zA6Udwdu3bkl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>NOTE 19 – <span id="xdx_82F_zN9V0OSqJQP3">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 2, 2026 the Company issued 1,109,837 shares of common stock for a total consideration of 17,135.88.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 12, 2026 the Company issued 993,358 shares of common stock for a total consideration of 19,2151.94.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 21, 2026 the Company issued 1,081,493 shares of common stock for a total consideration of $17,518.07.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 29, 2026 the Company issued 921,406 shares of common stock for a total consideration of $17,838.41.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On February 9, 2026 the Company issued 1,172,568 shares of common stock for a total consideration of $19,136.30.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On February 20, 2026, the Company issued 890,303 shares of common stock for a total consideration of 12,108.12.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On March 9, 2026, the Company issued 876,614 shares of common stock for a total consideration of $10,379.10.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On March 17, 2026, the Company issued 1,998,326 shares of common stock for a total consideration of $20,622.72.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 2, 2026 the Company issues, 2,011,019 shares of common stock for a total consideration of $14,961.98.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p>